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ABSTRACT 
Association of Smooth Muscle Myosin and its Carboxyl Isoforms with Actin 
Isoforms in Aorta Smooth Muscle 
By Jason Edward Black 
 The contraction mechanism of smooth muscle is not fully understood.  The primary interaction 
that leads to the formation of tension, the myosin-actin crossbridge, has been studied extensively.  
However, even this aspect of the contraction has proven not to be as simple as it might seem.  There 
are several isoforms of smooth muscle myosin and actin, and the differences in the activities of these 
isoforms and their interactions during the contractile process are largely unknown.  The studies to be 
discussed are directed at the determination of the interaction of these isoforms during the contraction 
of rat aortic smooth muscle.  Chapter II describes the association of smooth muscle myosin with two of 
the actin isoforms found in smooth muscle, α-actin and β-actin, using a novel method of fluorescence 
resonance energy transfer (FRET) to examine this association in both the A7r5 cell model and in intact 
tissue.  We show that the contractile apparatus undergoes significant remodeling during contraction 
and that the interaction of myosin with α-actin and β-actin is different at the various time points of 
contraction.  In Chapter III, we describe more detailed experiments examining the two different 
myosin tail isoforms, SM1 and SM2.  The results of these studies confirm our findings of remodeling 
of the cytoskeleton and the contractile apparatus during contraction and show that α-actin and β-actin 
interact differently with these myosin isoforms.  The results provide the first direct evidence of 
contractile remodeling in smooth muscle and suggest that complex changes in actin-myosin interaction 
may be important in the contraction of this muscle type. 
 
 
 iii
DEDICATION 
True to my nickname (Church Guy) that Dr. Wright gave me, I want first and foremost to thank my 
gracious and loving Savior, Jesus, for His patience that He shows and strength that He gives day after 
day.  I would have no life without Him. 
 
I want to thank my wonderful parents who raised four very different children and enabled each of us to 
embrace our individual personalities and to pursue the goals we wanted.  With this degree I will finally 
move out of their house.  Thanks for your patience! 
 
I am thankful for my siblings and their families.  They help to remove my mind from the ivory tower 
every now and then and place me in everyday life.  They have given me great models of how I would 
like my future family to be, if ever it happens. 
 
I finally want to thank the two churches, Crown City Community Church and Crew Community 
Church, that I was a part of during my time in graduate school and the friends that I made during my 
time there.  Thank you for showing me how to live and challenging me to strive to make the world a 
better place.  A special thanks to Rich, thanks for encouraging me to keep asking questions in search of 
the truth. 
 
 
 
 
 
 iv
ACKNOWLEDGEMENTS 
I feel like I have attended graduate school twice during my time at Marshall.  I want to thank my first 
lab, the Bryda lab, for introducing me to the world of research.  Thanks Dustin for teaching me 
Western blotting, among other things.  Thanks Sarah for encouraging me to be a better researcher and 
showing me how.  Thanks Josh and Jennifer for being friends.  Also, Thanks to Ian for being the best 
lab technician I have worked with.  Also, thanks to those in the Microbiology Department for all the 
ways to helped me and taught me even after I had changed labs.  
 
Thanks Brandi, my second favorite lab tech, and to Ryan for helping with the ApoA1 project, although 
not much came of it. 
 
Thanks to Ava, Sean and Dawn for making my transition into the Wright lab as easy as possible.  
Thanks for all your help and your friendship.  Thanks to Aileen for knocking some sense into me every 
now and then.  Thanks Kan, Nancy, and the many other graduate students, technicians, etc. that were 
always ready to help me or to talk about whatever, thanks so much. 
 
Thanks to my committee: 
Dr. Moore, thanks for kind words and challenging questions 
Dr. McCumbee for all your help in the ApoA1 world, but also for challenging life questions 
Dr. Green, thanks for all the things you let me borrow, I hope you forgive my tab 
Dr. Bryda, thanks for being a great mentor in the beginning and a great friend through it all 
Finally, Dr. Wright thanks for challenging and mentoring me and for giving me a lab to join when I 
needed to make a big change.  I at least owe the last half of my Graduate career to you!  
 v
Table of Contents 
ABSTRACT………………………………………………………………………………………...….ii 
DEDICATION……………………………………………………...………………………………….iii 
ACKNOWLEDGEMENTS…………………………………………………………………………...iv 
TABLE OF CONTENTS……………………………………………………………….……………..v 
LIST OF FIGURES………………………………...………………………………………………...vii    
LIST OF TABLES…………………………………………….……………………………………….ix    
LIST OF SYMBOLS/ABREVIATIONS……………………………...……………………………...xi      
CHAPTER I……………………………………………………………………….……………………1 
 GENERAL INTRODUCTION………………………………………………………………….1 
 DISSERTATION ORGANIZATION…………………………………………………………...1 
 SMOOTH MUSCLE CONTRACTION………………………………………………………...1 
 CYTOSKELETAL REMODELING…………………………...………………………………10 
 MYOSIN REMODELING………………………………………………..……………………12 
 THE FAMILIES OF MYOSIN……………………………………………………..………….14 
 SMOOTH MUSCLE MYOSIN……………………………………………………………..…17 
 FUNCTION OF MYOSIN ISOFORMS…………………………………………..…………...28 
 FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET)……………………..…...32 
 REFERENCES………………..………………………………………………………………..36 
CHAPTER II………………………………….………………………………………………………51 
 FRET ANALYSIS OF ACTIN/MYOSIN INTERACTION IN CONTRACTING RAT 
AORTIC SMOOTH MUSCLE…………………………..…………………………………………….51 
 ABSTRACT………………………………………………..…………………………………..52 
 vi
 INTRODUCTION…………………………………………………..……………………….…53 
 METHODS…………………………………………………………………..…………………55 
 RESULTS……………………………………………………………………………..………..60 
 DISCUSSION…………………………………..………………………………………………76 
 REFERENCES…………………………………………..……………………………………..79 
CHAPTER III…………………………………………………………..……………………………..84 
 MYOSIN ISOFORM INTERACTION WITH ACTIN ISOFORMS IN A7R5 CELLS AND 
RAT AORTA SMOOTH MUSCLE……………………………………………..…………………….84 
 ABSTRACT………………………………………………………………………..…………..85 
 INTRODUCTION…………………………………………………………………………..….86 
 METHODS……………………..………………………………………………………………88 
 RESULTS………………………………..……………………………………………………..94 
 DISCUSSION……………………………………..…………………………………………..109 
 REFERENCES…………………………………………….………………………………….112 
CHAPTER IV………………………………………………………………………………………..117 
 SUMMARY AND CONCLUSION…………………………………………………………..117 
 GENERAL DISCUSSION……………………………………………………………………117 
 FUTURE WORK………………………………………………………………………...…...119 
 CURRICULUM VITAE…………………………………………………………………...…121 
 vii
 
LIST OF FIGURES 
CHAPTER I.  GENERAL INTRODUCTION 
Figure 1.  Model of proposed smooth muscle ‘sarcomere’                                                                       2 
Figure 2.  Smooth muscle contraction mechanism                                                                                    4 
Figure 3.  Myosin/actin interaction during crossbridge cycling                                                                6 
Figure 4.  Smooth muscle relaxation mechanism                                                                                      7 
Figure 5.  Proposed model for role of HSP27 in smooth muscle contraction                                           8 
Figure 6.  Model of formation of myosin filaments by myosin monomers                                            13 
Figure 7.  Structure of myosin II                                                                                                             15 
Figure 8.  Diagram of smooth muscle myosin heavy chain isoforms                                                     26 
 
CHAPTER II.  FRET ANALYSIS OF ACTIN/MYOSIN INTERACTION IN CONTRACTING 
RAT AORTIC SMOOTH MUSCLE 
Figure 1.  Time intervals selected for FRET analysis of rat aortic smooth muscle                                64 
Figure 2.  Dual immunostaining of α-actin and myosin in A7r5 cells                                                    65 
Figure 3.  FRET analysis of α-actin/myosin complex in A7r5 cells                                                       66 
Figure 4.  Dual immunostaining of β-actin and myosin in A7r5 cells                                                    67 
Figure 5.  FRET analysis of β-actin/myosin complex in A7r5 cells                                                       68 
Figure 6.  Rat aortic smooth muscle dual stained with phalloidin and TO-PRO-3 iodide                      69 
Figure 7.  Dual staining of a control tissue section for α-actin and myosin                                            70 
Figure 8.  FRET analysis of α-actin/myosin in aortic tissue section                                                       71 
Figure 9.  FRET images showing α-actin/myosin structure in relation to cell nuclei                             72 
 viii
 
CHAPTER III.  MYOSIN ISOFORM INTERACTION WITH ACTIN ISOFORMS IN A7R5 
CELLS AND RAT AORTA SMOOTH MUSCLE 
Figure 1.  Dual immunostaining of α-actin and SM2 in A7r5 cells                                                        97 
Figure 2.  Dual immunostaining of β-actin and SM2 in A7r5 cells                                                        98 
Figure 3.  Dual immunostaining of α-actin and SM1 in A7r5 cells                                                        99 
Figure 4.  Dual immunostaining of β-actin and SM1 in A7r5 cells                                                      100 
Figure 5.  Dual immunostaining of α-actin and SM2 in aorta tissue                                                     101 
Figure 6.  Dual immunostaining of β-actin and SM2 in aorta tissue                                                     102 
Figure 7.  Dual immunostaining of α-actin and SM1 in aorta tissue                                                     103 
Figure 8.  Dual immunostaining of β-actin and SM1 in aorta tissue                                                     104 
Figure 9.  Western blot of α-actin co-immunoprecipitation                                                                  105 
Figure 10.  Western blot of β-actin co-immunoprecipitation                                                                106 
 
 
 
 
 
 
 
 
 
 
 ix
 
LIST OF TABLES 
CHAPTER II.  FRET ANALYSIS OF ACTIN/MYOSIN INTERACTION IN CONTRACTING 
RAT AORTIC SMOOTH MUSCLE 
 
Table 1.  Fluorescence resonance energy transfer (FRET) analysis of the association of myosin with α- 
and β-actin in Control and PDBu-stimulated A7r5 cells                                                                         73 
 
Table 2.  FRET analysis of the association of myosin with α- and β-actin in rat aortic smooth muscle  
                                                                                                                                                                 74 
Table 3.  F-actin content of tissue sections obtained from aortic segments before contraction with 
PDBu, at the beginning of force development, approximately midway through the contraction, and 
after the plateau in force development                                                                                                    75 
 
 
CHAPTER III.  MYOSIN ISOFORM INTERACTION WITH ACTIN ISOFORMS IN A7R5 
CELLS AND RAT AORTA SMOOTH MUSCLE 
Table 1.  Fluorescence resonance energy transfer (FRET) analysis of the association of SM2 myosin 
with α- and β-actin in Control and PDBu-stimulated A7r5 cells.                                                         107 
 
Table 2.  Fluorescence resonance energy transfer (FRET) analysis of the association of SM1 myosin 
with α- and β-actin in Control and PDBu-stimulated A7r5 cells.                                                         107 
 
 x
Table 3.  Fluorescence resonance energy transfer (FRET) analysis of the association of SM2 myosin 
with α- and β-actin in Control, Beginning, Midpoint, and Endpoint time points of PDBu-stimulated rat 
aorta smooth muscle tissue.                                                                                                                   108 
 
Table 4.  Fluorescence resonance energy transfer (FRET) analysis of the association of SM1 myosin 
with α- and β-actin in Control, Beginning, Midpoint, and Endpoint time points of PDBu-stimulated rat 
aorta smooth muscle tissue.                                                                                                                   108 
 
Table 5.  Co-immunoprecipitation experiment results.                                                                         109 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 xi
LIST OF SYMBOLS/ABREVIATIONS 
Å  angstrom 
ADP  adenosine diphosphate 
ANOVA analysis of variance 
ATP  adenosine triphosphate 
AVM  arteriovenous malformations 
CaM  calmodulin 
CaP  calponin 
CCD  charge coupled device 
cDNA  complementary DNA 
CO2  carbon dioxide 
CPI-17 protein kinase C-dependent phosphatase inhibitor – 17 kDa 
DAG  diacylglycerol 
DMEM Dulbecco’s modified Eagle’s medium 
E  transfer efficiency  
EB  esophageal body 
ELC  essential light chain 
ERK  Extracellular-signal-regulated kinase 
F-actin filamentous actin 
Fd  fluorescence of the donor in the absence of the acceptor 
Fda  fluorescence of the donor in the presence of the acceptor 
FRET  fluorescence resonance energy transfer 
GTP  guanosine triphosphate 
 xii
 
 
HSP20 heat shock protein – 20 kDa 
HSP27 heat shock protein – 27 kDa 
IP3  inositol, 1,4,5-trisphosphate 
J overlap integral between donor emission spectrum and acceptor absorption spectrum  
k dipole orientation factor  
LES  lower esophageal sphincter 
LC17  17 kDa light chain – essential light chain 
MAPK mitogen-activated protein kinase 
MHC  myosin heavy chain 
MLC  myosin light chain 
MLCK myosin light chain kinase 
MLCP myosin light chain phosphatase 
mRNA messenger RNA 
n  refractive index of the medium 
NM-A  non-muscle myosin A 
NM-B  non-muscle myosin B 
NMMHC non-muscle myosin heavy chain 
nt  nucleotide 
PBOO  partial bladder outlet obstruction 
PBS  phosphate-buffered saline 
PDBu  phorbol-12, 13-dibutyrate 
 xiii
PKA  protein kinase A 
PKC  protein kinase C 
PKG  protein kinase G 
PMA  phorbol 12-myristate 13-acetate 
PVDF  polyvinylidene fluoride 
Qo  quantum yield of the donor 
r  distance between two donor and acceptor in FRET system 
Ro  Förster distance 
RLC  regulatory light chain 
ROCK Rho-associated kinase 
SR  sarcoplasmic reticulum 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SEM  standard error of the mean 
Sm1  204 kDa smooth muscle myosin tail isoform 
Sm2  200 kDa smooth muscle myosin tail isoform 
SM-A  smooth muscle myosin heavy chain head isoform without insert 
SM-B  smooth muscle myosin heavy chain head isoform with insert 
SMC  smooth muscle cells 
SMHC smooth muscle myosin heavy chain 
TL  tailless  
Vmax  maximum enzymatic velocity 
WT  wild type 
ZIP  zipper-interacting protein kinase 
 1
Chapter I 
General Introduction 
Dissertation Organization 
 This dissertation will be presented in four chapters.  The first chapter is a review 
of the relevant topics that will be addressed in the chapters that follow.  Chapter two is a 
manuscript that has been submitted to Acta Physiologica and is currently under review at 
the time of this writing.  This chapter addresses the remodeling of myosin in both the 
A7r5 cell model and in rat aortic smooth muscle and myosin’s interaction with actin 
isoforms.  We found that myosin does appear to remodel during contraction and that its 
interaction with α-actin appears to be quite different from its interaction with β-actin.  
The third chapter is a manuscript that will soon be submitted that examines the 
remodeling of the smooth muscle myosin tail isoforms and their association with actin 
isoforms in both cell and tissue models.  The myosin isoforms were found to interact 
differently with the two actin isoforms studied.  Both studies used confocal microscopy 
and a novel fluorescent resonance energy transfer technique developed in our laboratory.  
The final chapter examines and discusses the results of the two manuscripts and 
addresses the possible future studies that could be performed. 
 
 
Smooth muscle contraction   
      Smooth muscle contraction is an integral part of mammalian physiology.  It is 
responsible for the motility of food through the digestive tract as well as the transport of 
blood and the regulation of blood pressure throughout the cardiovascular system.  It is 
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also present in hollow organs such as the urinary bladder and in the air passages of the 
respiratory system.    
There are many differences between smooth muscle contraction and that of 
skeletal or cardiac muscle.  Striated muscle derives its name from the presence of 
repetitive structures (sarcomeres) which are absent in smooth muscle.  Some studies have 
suggested the presence of repetitive sarcomere-like structures (Figure 1) in smooth 
muscle (Herrera et al. 2005).  In this structure, dense bodies replace the Z-bands that are 
seen in skeletal muscle, but actin remains the primary component of the thin filaments 
and myosin remains the primary component of the thick filaments.  The contractile 
filaments are thought to be arranged in parallel to the longitudinal axis in smooth muscle 
with the actin filaments attached to dense plaques at the cell membrane.  These in turn are 
attached to other dense plaques in adjacent cells, allowing these cells to act as a 
mechanical syncytium and to function as a group (Kuo and Seow 2004).  However, it 
should be noted that this model remains speculative and conclusive evidence for its 
validity remains to be obtained. 
 
 
Figure 1:  Model of the proposed smooth muscle ‘sarcomere’ with dense bodies replacing the 
more well-known Z-bands that are seen in the sarcomere of skeletal muscle.  Modified from 
Herrera et al. (2005). 
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Skeletal muscle responds much more quickly (milliseconds) to stimuli than 
smooth muscle, which takes one to three seconds to respond (Guyton and Hall 2000).  
However, smooth muscle has been shown to better maintain contraction with less energy 
expenditure than skeletal muscle (Paul 1983).  Another difference is that for contraction 
to occur in skeletal muscle, the apparatus needs to be de-inhibited, but in smooth muscle 
the apparatus must be activated.  The average force exerted by smooth muscle myosin 
has been found to be three times that exerted by the myosin of skeletal muscle (VanBuren 
et al. 1994).  Smooth muscle contraction in its entirety may not be as well understood as 
that of skeletal muscle, but several components and pathways have been described.   
      The primary pathway of smooth muscle contraction (Figure 2) is initiated by the 
influx of Ca2+ into the cytosol of smooth muscle cells (Vorotnikov et al. 2002; Webb 
2003).  The influx of these ions is from the extracellular space and is caused by the 
opening of ligand-operated calcium channels in the membrane.  The resulting increase in 
intracellular calcium is supplemented with Ca2+ released from the sarcoplasmic 
reticulum.  The neural agonist, norepinephrine, binds to a receptor which increases the 
activity of phospholipase C in the cell membrane in conjunction with a G protein.  RhoA 
plays a significant role in mediating this G protein pathway (Fujihara et al. 1997), which 
results in the production of inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) 
from phosphatidylinositol 4,5-bisphosphate.  IP3 signals the sarcoplasmic reticulum to 
release Ca2+ and DAG activates the protein kinase C (PKC) pathway (Webb 2003).   
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Figure 2:  Contraction mechanism of smooth muscle showing the result of extracellular Ca2+ and the 
agonist activation of contraction.  Ca2+ enters the cytoplasm mostly from the extracellular space; however, 
some enters from the sarcoplasmic reticulum (SR).  An agonist binds to a receptor that is associated with a 
G-protein and phospholipase C catalyzes the production of IP3 and DAG (not shown) and IP3 causes release 
of Ca2+ from the SR.  Ca2+ binds to CaM, that complex binds to and activates MLCK.  This complex 
phosphorylates the myosin RLC, activating myosin to bind actin.   Modified from Barany (1996).  
   
Calmodulin (CaM) is activated when four Ca2+ ions are bound forming Ca/CaM, 
and this complex then activates myosin light chain kinase (MLCK) by binding to it.  The 
Ca/CaM/MLCK complex is responsible for phosphorylating the regulatory light chain 
(RLC) of smooth muscle myosin II.  This phosphorylation activates the myosin and 
enables it to bind to actin filaments.  Work in our laboratory also suggests that MLCK 
Myosin
Actin 
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plays a structural role, keeping myosin and actin filaments in register, and then allowing 
the filaments to slide during contraction. (Thatcher, et al. in review) 
Ca/CaM may also aid in preparing the actin filaments for myosin binding by de-
inhibiting the actin filament via alterations in caldesmon (Vorotnikov et al. 2002).  
Caldesmon is a protein that has been shown to bind to actin thin filaments.  Caldesmon 
also has domains that bind to another thin filament protein, tropomyosin.  Caldesmon has 
also been shown to bind to myosin (Gusev 2001) and to inhibit its ATPase activity 
(Gorenne et al. 2004) as a result of its secondary binding to actin filaments (Borovikov et 
al. 2004).  How this inhibition mechanism operates has been a matter of debate, but may 
center around the ability of this molecule to engage the tropomyosin molecule in 
opposition to myosin movement (Graceffa and Mazurkie 2005).  Together these results 
suggest that although the full effect of caldesmon on smooth muscle contraction is not 
known, the molecule does have a role in the association of myosin with actin and the 
resulting contraction.  Once myosin is activated by the phosphorylation of at least one of 
the RLCs (Rovner et al. 2006), the myosin head then binds to actin and forms the actin-
myosin crossbridge.  Myosin will stay attached to the actin filament until ATP binds to 
the myosin head.  Myosin hydrolyzes ATP into ADP and Pi and converts this chemical 
energy into mechanical energy.  The myosin head binds to the actin filament and with the 
release of the ADP and Pi from the myosin molecule performs the “power stroke” pulling 
actin.  Figure 3 illustrates this myosin/actin crossbridge cycle.  Contraction is terminated 
once myosin is inactivated by the dephosphorylation of the regulatory light chain by 
myosin light chain phosphatase (MLCP).    
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Figure 3:  The interaction of myosin with actin fibers during crossbridge cycling in muscle contraction.  
fig.cox.miami.edu/~cmallery/150/neuro/c49x33muscle-cycle.jpg 
       
MLCP is the primary phosphatase for removing the phosphate from the regulatory 
light chain of myosin and initiating relaxation of the smooth muscle cell (Figure 4).  
MLCP is regulated in multiple ways.  CPI-17, which is activated by PKC, is the primary 
inhibitor of MLCP.  MLCP can also be inhibited by Rho kinase via the ZIP kinase 
pathway.  The inhibition of MLCP results in the myosin light chain remaining 
phosphorylated longer which increases contraction of the smooth muscle cell.
“Power 
Stroke” 
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Figure 4:  Smooth muscle relaxation mechanism illustrating the expelling of Ca2+ from the intercellular 
space and the activity of MLCP dephosphorylating MLC.  (Webb 2003).  
 
The activity of PKC can also lead directly to the activation of myosin.  PKC can 
phosphorylate MAP kinase, which can then activate MLCK.  MAP kinase can also 
phosphorylate and deactivate caldesmon, preparing actin for myosin binding.  PKC has 
also been shown to induce actin rearrangements (Brandt et al. 2002).  In studies using 
myosin II heavy chain knockout mice, cerebral arteries were only able to contract when 
treated with PMA, which works through the PKC pathway, but did not contract when 
treated with K+.  However, control vessels contracted under both treatments (Lohn et al. 
2002).  Based on these observations, the authors suggested that another motor protein 
operates under the influence of the PKC pathway.    
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 There are potentially other proteins that play roles in the contraction of smooth 
muscle that are not yet fully understood.  Heat shock proteins (HSPs) HSP27 and HSP20 
have been found to be involved in contraction and relaxation, respectively, of smooth 
muscle.  HSP27 can be phosphorylated by PKC and can lead to the contraction of smooth 
muscle (Bitar et al. 1991).  HSP20 is phosphorylated by PKA and PKG and this 
activation has been found to lead to relaxation of smooth muscle (Brophy et al. 1999; 
Brophy et al. 1999).  How these molecules perform these actions is not fully understood.  
HSP27 has been found to form filaments and it is thought that these may bind to actin 
and tropomyosin (Somara and Bitar 2004) helping to inhibit myosin attaching to the actin 
filament (Figure 5).  In rabbit colon smooth muscle cells, HSP27 has been shown to 
maintain MLC phosphorylation by mediating the association of RhoA with ROCK-II.   
HSP20 has structural similarities to troponin I, which inhibits myosin-actin binding in 
skeletal muscle.    
 
Figure 5:  Proposed model for the role of HSP27 in smooth muscle contraction demonstrating that 
phosphorylation of HSP27 results in actin being exposed to myosin binding.  Modified from Bitar (2003). 
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RhoA is a ras-related GTP-binding protein.  It has been shown that the activation 
of rho can induce the phosphorylation of MLC and the formation of stress fibers 
(Chrzanowska-Wodnicka and Burridge 1996).  RhoA has been shown to translocate to 
the membrane when rabbit portal vein cells were sensitized with Ca2+.  From this 
position, rhoA can be readily activated to initiate a signaling cascade involved in smooth 
muscle contraction (Gong et al. 1997).  RhoA has been shown to be activated by stretch 
with evidence that the signaling cascade activated may include ERK (Numaguchi et al. 
1999).  However, this rhoA-mediated Ca2+ sensitization played a greater role in smooth 
muscle contraction induced by an agonist in rat pulmonary artery than in aorta (Hyvelin 
et al. 2004).  Also, when rhoA activity was decreased in A7r5 cells by addition of the rho 
inhibitor Y-27632, actin fibers were seen to disassemble (Brandt et al. 2002).  In rabbit 
aortic smooth muscle cells, rhoA was shown to promote the contractile phenotype (Worth 
et al. 2004).  Rho kinase was also found to bind to non-muscle myosin fibers (Kawabata 
et al. 2004).  All of these studies suggest that rho plays a very active role in smooth 
muscle contraction. 
Another molecule that may play an important role in smooth muscle contraction is 
calponin (CaP).  Evidence has been found for an inhibitory role of CaP in the myosin 
ATPase.  Studies have also suggested that CaP may play a role in signaling cascades.  
CaP has been shown to associate with ERK and PKC (Morgan and Gangopadhyay 2001). 
Taken together, the existing data suggests an extraordinarily complex mechanism 
of biochemical regulation of contraction in smooth muscle. 
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Cytoskeletal Remodeling  
 The mechanism underlying the ability of smooth muscle to maintain contraction 
with minor energy expenditure has been a central issue of debate.  One hypothesis known 
as the latch state proposes that the crossbridges between myosin and actin somehow 
begin to cycle slowly, causing the cell to remain contracted.  Mathematical models have 
been developed to support this hypothesis, in which actin-binding proteins are proposed 
as regulators of actin and myosin association (Hai and Murphy 1992; Hai and Kim 2005).  
In addition, it has also been found that myosin can continue to be functional even if only 
one of its two RLCs is phosphorylated, thereby reducing the amount of ATP needed to 
maintain the activation of a myosin molecule (Rovner et al. 2006).  However, direct 
experimental evidence to support the latch hypothesis has not yet been reported.  An 
alternate hypothesis to explain the characteristics of smooth muscle contraction is that the 
contractile apparatus and supporting cytoskeleton may undergo remodeling (Battistella-
Patterson et al. 1997; Li et al. 2001). 
 According to the cytoskeletal remodeling hypothesis of contraction, the actin 
cytoskeleton within a smooth muscle cell changes form, or remodels, to allow the 
contractile apparatus to maintain optimal mechanical advantage throughout the 
contraction.  This hypothesis further proposes that the tension maintenance at low energy 
cost is due to cross-linking of actin filaments to hold the cell in the contracted 
configuration.  In A7r5 embryonic rat aorta cells, the transfer of actin into structures 
known as podosomes has been demonstrated when a stimulus of phorbol-12, 13-
dibutyrate (PDBu) has been administered (Fultz et al. 2000).  This compound is a DAG 
analogue and activates the PKC pathway which leads to contraction.  During this 
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contraction, actin forms columns of filaments on the edge of the cell (Fultz et al. 2000).  
This hypothesis has been tested in rat aorta tissue with the use of cytochalasin, a 
compound that inhibits the formation of actin filaments.  Cytochalasin reduces smooth 
muscle contraction, and it is thought that this reduction is due to the inhibition of actin 
remodeling (Wright and Hurn 1994).  
 One of the key elements of this hypothesis is the proposed differences in the α-
actin and β-actin isoforms which are found in vascular smooth muscle.  Studies have 
shown that the α-actin isoform is the first to enter the podosome while β-actin remains in 
filaments for a longer period (Fultz et al. 2000; Brown et al. 2006).  This suggests that 
tension is maintained by myosin binding to β-actin filaments until α-actin is remodeled in 
such a way as to maintain tension.  The podosome structures seen in cell culture have not 
been shown in contracting tissue, so it is unknown if a similar structure plays this role in 
tissue.  The isoforms of actin studied in our laboratory are very similar in structure.  
These proteins are of identical molecular weight with the difference traced to a few 
amino acid residues that result in α-actin being more acidic than β-actin (Owens and 
Thompson 1986; Khaitlina 2001).   
 Evidence supporting the cytoskeletal remodeling hypothesis include studies in 
canine trachealis smooth muscle in which actin polymerization was stimulated by 
contractile activation and this actin polymerization directly contributed to force 
development (Mehta and Gunst 1999).  These authors also suggested that actin 
remodeling contributes to the length sensitivity of canine tracheal smooth muscle 
contractility. 
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Myosin Remodeling  
 In addition to actin cytoskeleton remodeling, a few studies have shown that the 
thick filaments of smooth muscle may also be remodeled.  It has been shown that myosin, 
when it is not activated, is in a folded conformation (Trybus et al. 1982; Trybus and 
Lowey 1984).  This folded conformation has been examined by x-ray crystallography and 
it was found that portions of the “blocked” head and parts of the catalytic and converter 
domains and the ELC of the “free” head interacted, blocking actin binding (Liu et al. 
2003).  This conformation inhibits myosin from interacting with actin or forming 
filaments (Sweeney 1998).  The ability of myosin molecules to polymerize into thick 
filaments and to depolymerize from such filaments in different conditions suggests that 
myosin can remodel similarly to actin.  Early studies in canine airway smooth muscle 
revealed that, upon a quick change of muscle length, the ability of the muscle to contract 
was decreased (Gerthoffer and Gunst 2001).  Earlier studies showed that smooth muscle 
tissue can adapt to new lengths if the tissue remains at the new length for an adequate 
amount of time (Pratusevich et al. 1995).  Based on these findings it was suggested that 
contractile units in canine tracheal muscle are able to move and reform to allow for 
change in the optimal length of contraction.  Further, they proposed that this adaptation 
takes time and that only about 20% of the contractile units in the tissue are fixed.  Other 
studies have confirmed this slow reconformation of the contractile apparatus (Mehta et al. 
1996).  In addition, airway smooth muscle tissue has also been shown to maintain some 
memory of past optimal lengths (Chan et al. 2000), which supports the time requirement  
for a new optimal length to develop.  Hence, the data suggest that the actin-myosin 
contractile apparatus is plastic in nature and can adapt to changes in the external 
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environment, including rearrangement in response to stretch (Gerthoffer and Gunst 
2001).  The ability of smooth muscle to adapt its working length could allow for hollow 
organs to maintain appropriate functions with myosin remodeling dependent on actin 
structure (Seow 2005).  Figure 6 shows a model proposed to demonstrate how myosin 
monomers can use actin thin filaments to organize the location of the new thick filament. 
 
Figure 6:  Model illustrating the possible model showing the formation of myosin thick filaments by 
myosin monomers which are using actin thin filaments as a guide during airway smooth muscle cell length 
adaptation.  (Seow 2005).  
 There is significant experimental evidence supporting myosin contractile 
remodeling.  In porcine tracheal smooth muscle, activation of the muscle resulted in a 
144% increase in the density of myosin thick filaments (Herrera et al. 2002).  They also 
found that if Ca2+ was removed during the resting state, thick filament density decreased 
by 35%.  The authors state that there is an equilibrium that exists in these tissues of 
filamentous myosin with monomeric myosin.  This creates the conditions for myosin 
remodeling not only during changes in optimal tissue length, but also during contraction.  
a 
 
 
 
 
 
b 
 
 
 
 
c 
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In addition, stimulated porcine airway smooth muscle demonstrated an increase in thick 
filament formation (Smolensky et al. 2007), which was blocked by inhibition of MLC 
phosphorylation even when Ca2+ levels remained at stimulated levels.  Myosin 
remodeling has also been demonstrated in A7r5 cells in our laboratory (Fultz and Wright 
2003) showing that such activity can likely occur in the smooth muscle cells of rat aorta. 
 
The Families of Myosin 
 The motor protein that contracts muscle is myosin.  However, there is a great 
complexity of myosin isoforms and several forms of myosin may be found within a 
specific smooth muscle type.  Seventeen different families of myosin have been reported 
(Kendrick-Jones et al. 2001), however, another reports that there are eighteen classes 
(Berg et al. 2001).  These have been broken down into two categories of conventional 
and unconventional myosin. Conventional myosin consists of the family of myosins 
called myosin II which was the first myosin protein to be reported by Kuehne back in 
1864 (Spudich 1989).  Myosin II exists as a hexamer of two heavy chains and four light 
chains.  The largest component of these myosins, called the heavy chain, is comprised of 
a globular head region and an elongated tail.  The tails of two of these heavy chains 
combine in a coiled-coil configuration.  This complex therefore has two head regions and 
two tail regions.  Members of the myosin II class have two myosin chains which are 
associated via an α-helix of their tails and two light chains per heavy chain combining to 
form each myosin molecule (Figure 7).  The two heads of smooth muscle myosin II have 
been shown to work together during contraction to enable myosin to perform the 
optimum level of force development (Tyska et al. 1999; Lidke and Thomas 2002).   
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Figure 7:  Structure of the myosin II molecule.  Notice the two heavy chains interconnected by the long 
tail region and the two large globular heads.  Also seen here are the two essential light chains and the 
two regulatory light chains and their approximate locations 
www.cella.cn/book/09/images/image009.jpg.  
 
 The other 16 classes of myosin proteins are known as the unconventional myosins 
(Kendrick-Jones et al. 2001).  Not as much is known about these other classes.  Nine of 
these have been classified as having a single heavy chain which tends to be much shorter 
than in the conventional myosins (Kendrick-Jones et al. 2001).  The other seven do have 
regions of coiled-coil interactions and do form a complex containing two heavy chains 
(Kendrick-Jones et al. 2001).  All myosins possess an ATP-hydrolyzing motor domain 
that moves along actin filaments (Hasson and Mooseker 1996).  It is not known if all of 
the unconventional myosins have light chains, but a few have been found that do.  
However, these light chains are not always like those of myosin II.  In some cases 
calmodulin or calmodulin-like molecules bind to the heavy chain neck regions and act as 
Ca2+-binding light chains (Kendrick-Jones et al. 2001).  Not all of these myosin 
molecules are found in mammals.  The members of myosin families VIII, XI, and XIII 
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have only been found in plants with Myosin IV isolated only in amoebas and myosin XII 
only reported in C. elegans (Berg et al. 2001; Kendrick-Jones et al. 2001).  Myosin XIV 
has been found in parasitical protists, and myosin XVII has only been found in fungi 
(Berg et al. 2001; Kendrick-Jones et al. 2001).  Very little is known about myosin X and 
XVI, although both have been found in humans (Berg et al. 2001).  The remaining 
families have been found in mammals (Kendrick-Jones et al. 2001), and we will discuss 
them in more detail.   
Myosins have been proposed to play a multitude of important roles.  Myosin I has 
been subdivided into four subclasses with the differences being the amount of IQ binding 
motifs (regions where light chains can bind) and differences in the tail region (Kendrick-
Jones et al. 2001).  Myosin I proteins have only one heavy chain.  Several functions have 
been proposed for the myosin I molecules:  cell crawling, chemotaxis, and phagocytosis 
(Kendrick-Jones et al. 2001).  Subclass 1 molecules have one or two IQ motifs.  Subclass 
2 proteins are found at the cell membrane and contain 3-6 IQ motifs.  A very important 
member of this subclass is found in the microvilli (Hasson and Mooseker 1996).  Another 
member has been found in stereocilia and plays a role in hearing (Cyr et al. 2002).  
Subclass 3 proteins contain 3 IQ motifs and have been found in several tissues (Kendrick-
Jones et al. 2001).  They contain a tail region that can bind phospholipids.  Subclass 4 is 
similar to 3 but only has 2 IQ motifs (Kendrick-Jones et al. 2001).  There is still much to 
be resolved about the myosin I family of myosins, including their regulation within the 
cell (Kendrick-Jones et al. 2001).   
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 Myosin III has an N-terminal kinase domain, which is different from all other 
myosins (Kendrick-Jones et al. 2001).  This class of myosins has been found in the retina 
and could play a role in vision (Berg et al. 2001). 
 Myosin V molecules are dimeric (Hasson and Mooseker 1996) and serve as 
transport molecules within the cell which literally “walk” along the actin filament 
(Kendrick-Jones et al. 2001).  Myosin VI is similar to myosin V, although V binds 
several more light chains (Kendrick-Jones et al. 2001).  However, myosin VI is very 
different from other myosins.  All other myosins move toward the plus end of the actin 
filament; whereas, this class of myosin contains what has been called a reverse gear and 
can move toward the minus end of the actin filament (Diwan 2006).  Myosin VI also 
performs a role in the transport of items within the cell (Kendrick-Jones et al. 2001; 
Diwan 2006). 
 Along with myosin VI, VII and XV have been found to play roles in genetic 
deafness (Hasson and Mooseker 1996; Berg et al. 2001).  Several disorders have been 
linked to either the mutations or absence of these myosins within the ear, specifically 
affecting the stereocilia (Kendrick-Jones et al. 2001). 
 Myosin IX molecules are single-chained proteins expressed in several tissues.  A 
role has been proposed for myosin IX as a signaling molecule negatively regulating the 
Rho signaling pathways (Bahler 2000).   
  
Smooth Muscle Myosin 
 Smooth muscle myosin is one of the conventional myosins.  However, it is still a 
protein that has diverse forms.  This section will examine the isoforms of not only the 
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smooth muscle myosin heavy chain but also the isoforms of the light chains.  The 
difference in function of these different isoforms has been a matter of controversy.  I will 
trace the research of these isoforms from their discovery through the debate of their 
different functions.   
 The discovery of two myosin heavy chain isoforms was reported in 1986 (Rovner 
et al. 1986).  Of the two, the larger one in molecular weight was designated Sm1 while 
the smaller was designated Sm2 (Rovner et al. 1986).  SDS-PAGE was used to examine 
several protein extracts from multiple smooth muscle tissues in which a 1:1 ratio of Sm1 
to Sm2 was observed in most tissues.  The authors suggested that these isoforms of 
myosin could form either heterodimers or homodimers, but were unable to determine 
which was dominant.  In a later study, researchers were able to separate the heavier 
isoform form the lighter using an antibody specific only for the 204kDa heavy chain 
(Kelley et al. 1992).  These investigators found that immunoprecipitations of Sm1 did not 
contain any Sm2 in either bovine aortic cells or in turkey gizzard suggesting the isoforms 
existed as homodimers.  Another study, focusing on aorta muscle cells from the rat 
(Kawamoto and Adelstein 1987) found using protein gels three bands in the 200kDa 
region.  2-D peptide maps showed the 204 and 200kDa bands to be very similar while the 
196kDa protein was largely different from the two heavier bands.  They did not find a 1:1 
ratio of the two heavier bands, presumably Sm1 and Sm2, but found Sm1 to be 59% of 
the additive total of the two bands and Sm2 to be 41%.  The authors also found 
differences in expression depending on the state of the cell culture (log phase, 
postconfluent, etc.).  The 196kDa protein was much more highly expressed than the other 
two, and the 200kDa protein was expressed very little.  In the log phase of the culture no 
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200kDa protein was expressed.  Hence, not only are there different myosin isoforms, but 
the expression levels may change.  So, two tail isoforms have been reported which exist 
as homodimers and are variable in expression.  A major question emerging from these 
studies is, despite the great similarity in the protein sequences of Sm1 and Sm2, could 
they be involved in different functions of the cell? 
To answer this question a later study utilized a rabbit uterine cDNA library, in 
which SMHC29 was used as a probe (Nagai et al. 1989).  The authors had previously 
determined that this clone encoded for tail region of smooth muscle myosin (Nagai et al. 
1988).  Positive clones were examined further and it was found that three were positive 
for SMHC29, but eight were positive for clones of larger sizes.  These were called 
SMHC40 and were found to encode for a myosin chain with 43 unique amino acids in a 
region of the protein in which SMHC29 encoded for 9 unique amino acids.  S1 nuclease 
mapping determined that SMHC40 was expressed in all smooth muscle tissue examined.  
However, neither was expressed in skeletal muscle or brain tissue and only slightly 
expressed in cardiac muscle.  Antibodies were isolated that were specific to synthetic 
peptides encoded by SMHC40 or SMHC29.  The antibodies raised against SMHC40 
bound to the Sm1 band in rabbit aorta and the antibodies to SMHC29 bound specifically 
to the Sm2 band in Western blot analysis.  The authors claimed to see this in stomach, 
intestine, and urinary bladder as well.  They concluded that the difference between 
SMHC40 and SMHC29 was a 39nt insert and they concluded that mRNA that contains 
this 39nt insert encodes for Sm2, while the mRNA without the insert encodes for Sm1.  A 
study published the same year examined a rat aorta cDNA library and found two cDNAs 
for myosin heavy chain (Babij and Periasamy 1989).  The only difference observed was 
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in the carboxy terminus.  These authors also determined that one cDNA encoded 43 
unique amino acids and that another encoded nine in the tail region because of a 39nt 
insert.  The authors also determined that on each side of this insert were a 2600nt intron 
and a 2700nt intron, claiming that this was the first time that alternative RNA processing 
was shown in vertebrate myosin production.  Hence, it was concluded that the same gene 
encodes for these two tail isoforms. The authors also found this mRNA to be present in 
both vascular and non-vascular tissue.  These studies show that the difference between 
the smooth muscle myosin tail isoforms results from alternative splicing of the mRNA.  
This alternative splicing of mRNA results in an insert of 39nt in the message for Sm2, 
and a shorter protein. 
Myosin tail isoforms have been shown to be present in different smooth muscle 
tissues.  Several studies have been done to further examine this.  One such study 
examined two myosin heavy chain isoforms, but these authors determined the molecular 
weights to be 207kDa, which they called MHC1, and 204kDa, called MHC2 
(Schildmeyer and Seidel 1989).  They compared several smooth muscle types in several 
species.  They did find differences in expression between species, which was not 
surprising.  Specifically, in examining rat aorta tissue they determined the ratio of MHC1 
to MHC2 to be 55:45.  They also determined that the reaction of a monoclonal antibody 
against MHC was different between rat aorta and rat uterus.  Another study saw 
differences when comparing tissue from different aged rats (Eddinger and Murphy 1991).  
In young rats, the ratio of Sm1 to Sm2 was 0.5 in aorta and 2.7 in bladder.  Those ratios 
changed in older animals to 1.2 and 1.7, respectively.  Research has also shown a 
difference in Sm1 and Sm2 expression between fetal and adult tissue (Kuro-o et al. 
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1989).  Sm1 was seen by immunohistochemistry to be expressed in the fetus (25-28 days 
gestation) up to 30 days after birth.  Sm2 was not visualized until 20 days after birth, 
suggesting that the expression of these isoforms is developmentally regulated.  These 
authors also used gel electrophoresis to examine Sm1 and Sm2 expression.  They found 
two bands running where Sm1 and Sm2 would be expected to run in samples taken from 
fetal animals to those four months after birth.  The band migrating at 204kDa reacted 
with the Sm1 antibody.  The band migrating at 200kDa, however, did not react with the 
antibody specific to Sm2, suggesting that this protein band is different than the Sm2 
protein.   Another study found a similar protein band (Babij et al. 1992).  This study 
combined RNase protection assays with protein gel electrophoresis to determine that 
aorta tissue expressed more Sm1 and Sm2 than isolated cells.  With the RNase protection 
assay, these researchers found the ratio to be 80:20 of Sm1 to Sm2 in intact aorta.  The 
expression of each decreased in isolated cells, but the decrease of Sm2 was greater than 
that seen of Sm1.  The study also found that another isoform of myosin, non-muscle 
myosin heavy chain A (NMMHC-A) increased in cell culture when compared to intact 
aorta, changes also seen with protein gels.  The protein studies did reveal a protein band 
that migrated to about 200kDa but only reacted with the Sm1 antibody.  The authors 
reasoned that this band could be a result of the increased amount of NMMHC-A, which 
raises the problem of the specificity of the Sm1 antibody.  These studies show that the 
myosin tail isoforms are developmentally regulated and that non-muscle myosins do exist 
and play active roles even in smooth muscle tissue.    
 The possible different roles of each of the tail isoforms are still being studied.  A 
very interesting experiment was performed on individual smooth muscle cells (SMCs) 
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from rabbit arteries (Meer and Eddinger 1997).  The cells were contracted and mRNA 
was extracted from each cell.  A large variation was seen in the Sm2/Sm1 ratio ranging 
from 0.03 to 0.55.  When several parameters of the cells were measured and compared to 
the isoform content, only final cell length showed any significant correlation with the 
Sm2/Sm1 ratio.  As the amount of Sm2 increased the final length of the cell decreased.  
This suggests that the tail isoforms may differentially affect the structure of myosin 
filaments thereby affecting overall cell length.  Another study examined the affect of 
different smooth muscle myosin tail lengths on myosin filaments (Rovner et al. 2002).  
The authors started with chicken gizzard Sm1, and from that constructed Sm2 by 
replacing the chicken Sm1 tailpiece with that of Sm2 from rabbit.  They also constructed 
another form of the myosin tail that they denoted as tailless (TL) by placing a stop codon 
as the last codon before the alternative splice site.  All proteins were visible when 
analyzed by gel eletrophoresis.  Paracrystals of each isoform were examined with 
electron microscopy.  The crystals formed by each isoform were different although Sm2 
and TL were the most similar.  Repeating light and dark bands were visualized and the 
size of these bands were different when comparing the Sm1 crystals to those of Sm2 and 
TL.  The overall length of filaments formed was also different, with TL forming by far 
the longest filaments (801nm), with Sm1 (526nm) and Sm2 (512nm) being much shorter.  
It is surprising that with the Sm2 and TL crystals looking similar the length of the 
filaments was not more similar.  It was even more surprising that the length of Sm1 
filaments fell between that of TL and Sm2.  The tendency for each of these isoforms to 
form filaments was also examined.  TL was the most likely to form filaments followed by 
Sm1 and then Sm2.  The authors used viruses to infect insect cells with the Sm1 and Sm2 
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and found that homodimers of each isoform were preferred over heterodimers.  However, 
homodimers of Sm1 and Sm2 could copolymerize into thick filaments.  An earlier study 
found that the longer tail region of Sm1 contains a serine that is not present in Sm2 and 
that this serine can be phosphorylated by casein kinase II (Kelley and Adelstein 1990).  
This phosphorylation could play a role in filament formation (Babu et al. 2000).  So, 
myosin tail isoforms appear to play a role in filament length and cell structure. 
 Another way to examine the function of a protein is to look at it in 
pathophysiological conditions.  One such study examined the content of several myosin 
isoforms (nonmuscle and smooth muscle) in damaged left carotid arteries in Sprague-
Dawley rats compared to that of undamaged right carotids (Gallagher et al. 2000).  Sm1 
levels remained unchanged.  Sm2 levels decreased beginning at 24 hours after injury and 
remained reduced through seven days.  Non-muscle myosin A (NM-A) increased while 
non-muscle myosin B (NM-B) remained unchanged.  Microscopic examination revealed 
a change in where certain isoforms were expressed as well.  Cells expressing the two 
non-muscle isoforms were seen more in the intima and adventitia, while Sm1 expression 
seems unchanged overall and Sm2 expression was decreased overall.  One explanation is 
that changes in myosin isoform expression are important in cell dedifferentiation and 
migration from media into the damaged areas of the artery.  Hence, NM-A may be 
important for migrating cells.  Sm1 and NM-B are expressed in embryonic smooth 
muscle, but Sm2 is not.  These changes would be expected if such dedifferentiation and 
migration was taking place.  Another study looked at the results of a high cholesterol diet 
and certain drugs on the expression of myosin isoforms in rats (Itoh et al. 2002).  Sm1 
levels were unchanged, but Sm2 levels were decreased when compared to controls.  It 
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was also shown that within cells Sm2 levels decreased as oxidative stress increased.  The 
authors suggest that examination of Sm2 levels and oxidative stress may be a way of 
determining vascular dysfunction.  They further suggested that upregulating Sm2 may be 
a therapeutic way to lessen atherosclerosis.  Another study examined arteriovenous 
malformations (AVMs) from humans and compared them to normal arteries and veins 
(Hoya et al. 2003).  They found Sm1 and Sm2 present in internal carotid arteries, middle 
cerebral arteries and arteries greater than 30µm in diameter as well as in superficial 
middle cerebral veins and the transverse sinus.  The arterial component of the AVMs 
showed similar staining patterns to those of normal arteries.  However, the venous 
component often (from cerebral veins) showed staining patterns more like cerebral 
arteries and earned the name arterialized veins.  Changes in smooth muscle myosin tail 
isoform expression were seen in association with damage to blood vessels in rat, but not 
so clearly in humans.  However, this latter study only looked at whether or not Sm1 or 
Sm2 was expressed and not at the increase or decrease of expression levels as was 
examined in the two rat studies.  These studies show that smooth muscle myosin tail 
isoforms are expressed at different levels during different points of cell differentiation.  
 In addition to the complexity engendered by two tail isoforms, studies have found 
that the myosin heavy chain also has two other isoforms which differ in the head domain. 
The discovery of the myosin head isoforms was reported in the early 1990’s (Hamada et 
al. 1990).  Rabbit uterus smooth muscle myosin cDNA was examined, and the deduced 
protein sequences were compared to the known protein sequence of chicken gizzard 
smooth muscle myosin heavy chain (Babij et al. 1991).  The authors found that there was 
a difference of 13 amino acids including a 7 amino acid insert between the rabbit uterus 
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and chicken gizzard myosin heavy chains.  The difference was seen at the 25/50kDa 
junction in the myosin head region which is near the putative Mg2+-ATPase domain.  The 
authors also found that transcription for each isoform begins from a single site in the 
smooth muscle myosin heavy chain gene.  In another study (White et al. 1993), a fetal rat 
smooth muscle library was constructed and analyzed using smooth muscle heavy chain 
cDNA obtained from a rat stomach plasmid library as a probe.  The authors found two 
distinct cDNA smooth muscle heavy chain clones separated by only 21nt at the 25/50kDa 
junction in the S1 head region, strongly supporting the conclusions of Babij et al. (1991).  
White et al. named these two isoforms as SM1A (no insert) and SM1B (with insert), 
indicating their studies looked only at the SM1 tail isoform.  In addition, they determined 
the percentage of each isoform in several smooth muscle tissues.  In aorta 96% of the 
myosin content was the non-inserted form.  Vein, uterus, lung and stomach showed 70% 
or more SM1A content, small and large intestine showed a majority of SM1B and 
bladder showed 83% of the inserted isoform.  In another study, none of the inserted 
isoform was found in vascular tissue, leading the authors to term the isoforms as vascular 
(non-inserted) and visceral (inserted) (Babij 1993).  According to Babij (1993), by 
examination of cDNA clones, the inserted isoform was only seen with Sm1.  He further 
suggested a method of alternative splicing for the head isoforms in which exon 5a is 
joined to exon 6 in the non-inserted isoform.  The insert comes from an exon denoted as 
exon 5b.  Exon 5a is joined to 5b and then to 6 in the inserted mRNA.  To summarize 
these studies, the myosin heavy chain has another alternative splice site in the head 
region and this site generates two more heavy chain isoforms. 
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 The question of whether or not the inserted head isoform could be found in either 
of the tail isoforms was addressed by Low et al. (1999).  They examined airway smooth 
muscle as well as small blood vessels in rat lung tissue.  SM-B was found in airway 
smooth muscle as well in small blood vessels.  Large vessels with elastic laminae did not 
express SM-B; however, Sm1 and Sm2 were expressed in all the vessels examined.  
Septal tips and peripheral vessels showed a heterogeneous expression of SM-B and only 
expression of Sm1.  Tracheal smooth muscle expressed SM-B, Sm1 and Sm2.  The 
authors used an antibody specific for SM-B and found that SM-B was expressed in both 
Sm1 and Sm2.  So, as seen in figure 8 the smooth muscle myosin heavy chain can have 
four different isoforms that result from the two sites of alternative splicing of the mRNA 
from the one smooth muscle myosin gene. 
   
Figure 8:  Schematic diagram of smooth muscle myosin heavy chain isoforms. A: encoded regions 
involved in splicing of alternative exons and unique amino acids encoded by exons. B: 4 possible isoforms 
generated by alternative splicing at regions encoding carboxy terminus and junction of 25- and 50-kDa 
tryptic peptides. *, Stop codon (White et al. 1998).  
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Other myosin isoforms can be seen in the 17kDa essential light chain (LC17) that 
binds to the myosin heavy chain neck region and is thought to help stabilize the myosin 
heavy chain in this region (Lowey and Trybus 1995).  Two isoforms of LC17 have been 
isolated (Cavaille et al. 1986; Nabeshima et al. 1987).  The two isoforms were designated 
LC17a (acidic) and LC17b (basic) because of their isoelectric points at 4.13 and 4.19, 
respectively (Helper et al. 1988).  Tissues expressed each isoform in differing amounts 
(Helper et al. 1988) with the results only slightly different in comparisons of tissues 
between species.  However, when different tissue was compared within the same species, 
large differences were noted.  For example, porcine stomach was found to contain 100% 
LC17a, while aorta contained only 60% LC17a, and carotid artery had only 16% LC17a. 
Other laboratories examined individual SMCs for differences in SM2 and LC17 
expression.  Cells from rabbit carotid arteries had a lower percentage of SM2 mRNA than 
those from saphenous arteries (Sherwood and Eddinger 2002).  However, saphenous cells 
showed a lower percentage of LC17b mRNA than cells from carotid or femoral arteries.  
The authors also found that expression SM1/SM2 and LC17a/LC17b are not coregulated 
in the SMCs examined.  These studies show that other myosin isoforms exist as a result 
of alternative splicing of the mRNA for the ELC. 
Together, these studies indicate a complexity of smooth muscle myosin heavy and 
light chains that may give rise to multiple protein hexamers within the smooth muscle 
cell.  Several studies have looked at the expression of these proteins in different tissues, 
and based on the type of smooth muscle (e.g. tonic vs. phasic) tried to determine the 
characteristics of each isoform.  However, the question remains as to the function of 
multiple myosin isoforms. 
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Function of Myosin Isoforms 
Myosin has different forms throughout the different types of muscle.  In the early 
eighties a study was performed to examine the effects of the different myosin light chains 
on the enzymatic activity of different myosins (Wagner 1981).  Wagner examined cardiac 
and skeletal muscle myosin and was able to induce an exchange of essential light chains 
(ELC) between the two different myosins.  He determined that the Vmax did not change 
significantly when ELCs were exchanged, but the affinity for ATP was altered by these 
exchanges.  This suggests a possible link of the ELC to the affinity of the myosin 
ATPase.  However, ATPase velocity is thought to be regulated by the heavy chain.  
Throughout the years there has been much discussion about the different myosin heavy 
chain isoforms and their roles in smooth muscle.  The myosin tail isoforms have been 
found in both vascular and non-vascular muscle tissue (Babij and Periasamy 1989; Nagai 
et al. 1989).  However, Babij (1993) reported that the inserted head isoform was only 
present in non-vascular muscle, and that the non-inserted isoform was seen in both 
vascular and visceral muscle in studies in which only the Sm1 isoform was the inserted 
isoform examined.  On the other hand, White et al. (1993) did find small amounts of both 
head isoforms in vascular and visceral muscle tissue in similar studies examining the 
Sm1 isoform.  In rats, a wide range of percentages of the SmA and SmB isoforms were 
seen in the different tissues examined.  However, in a later study, the authors could not 
find the inserted isoform in cultured rat aortic cells, even though Sm1 and Sm2 were 
present in all tissues examined other than trachea (White et al. 1998).  However, others 
did find that the inserted head isoform existed in either of the tail isoforms (Kelley et al. 
1993).  These authors also determined that this insert had an effect on the Vmax of the 
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myosin Mg-ATPase.  In studies of turkey gizzard and aortic tissues, only the gizzard 
muscle contained the inserted head isoform and the Vmax of its ATPase was nearly two 
fold higher than that of aorta which had no detectable levels of insert isoform.  In 
agreement with the earlier results of Wagner (1981), the authors suggested that this seven 
amino acid insert, being near the ATP binding region in the myosin heavy chain, is 
specific for affecting the actin-activated Mg-ATPase of the myosin protein.  A doubling 
of the Vmax was confirmed in a later study by Rovner et al. (1997).  However, they did 
not find that variation in the ELC isoforms changed the function of myosin.   
In rabbit, thoracic and abdominal aorta did not contain detectable amounts of the 
inserted isoform, but femoral and saphenous arteries contained both SM-B and SM-A 
isoforms (DiSanto et al. 1997).  These studies also showed that the Vmax of the myosin 
ATPase in saphenous artery was twice that of aorta.  Both tail isoforms were detected in 
aorta and the femoral-saphenous samples.  Another characteristic that these authors 
examined was RLC phosphorylation.  They found that phosphorylation levels were 
similar in aorta, femoral-saphenous, and bladder samples.  In these same tissues, the 
percentage of LC17b was 45%, 18% and 4%, respectively.  In aggregate, the results 
suggest that LC17 isoform differences do not affect RLC phosphorylation.   
To this point, all of these studies described have compared tonic and phasic 
muscles from different systems (arteries compared to bladder compared to intestines).  
However, a study was done that compared in the same tissue tonic lower esophageal 
sphincter (LES) muscle to that of phasic esophageal body (EB) circular muscle 
(Szymanski et al. 1998).  They found the amounts of Sm1 and Sm2 to be similar in these 
two muscles.  However, EB contained 2-3 times more of the head insert than LES.  They 
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also found that there was 3-4 times more LC17a in EB than in LES.  Another group of 
researchers did something similar by examining rabbit bladder (phasic) in comparison 
with tissue from urethra (tonic) (Hypolite et al. 2001).  The authors also divided the 
bladder into three sections, dome, midbody, and base.  They did not find any difference 
in the expression of Sm1 and Sm2 mRNA in any of these bladder regions, but there was a 
significant difference in the Sm2:Sm1 ratio when comparing dome (2:1) to urethra 
(1.5:1.0).  The head isoforms were also examined showing that SM-B isoform mRNA 
copy numbers were much higher than those for SM-A in both bladder and urethra tissue.  
The authors also found significant differences in RLC phosphorylation levels when 
comparing dome, midbody, base, and urethra in resting tissue.  After contraction with K+, 
bladder and urethra tissue RLC phosphorylation increased up to 50% of force 
development.  This leveled off for urethra tissue between 80% and 100% of force.  
However, bladder muscle showed only a slight increase between 50 and 80% force, 
which was followed by a large decrease to near basal levels at 100% force.  The authors 
concluded that the different mix of myosin isoforms and the differences in RLC 
phosphorylation in the bladder and urethra play significant roles in the phasic nature of 
the bladder and the tonic nature of the urethra. 
Several studies have utilized bladder smooth muscle as the primary tissue in order 
to better understand the roles of myosin isoforms.  One such study compared amounts of 
Sm1 to maximal force generation in adult and newborn bladders in mice (Wu et al. 
2004).  Sm1 expression was highest in the newborn animals, as was the maximal force 
generated by the muscle.  Both Sm1 expression and maximal force decreased as the 
animals aged, suggesting a potential role of Sm1 in maximal force generation.  Another 
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model used surgically-induced partial bladder outlet obstruction (PBOO) which has been 
studied in both mouse (Austin et al. 2004) and rabbit (Mannikarottu et al. 2005).  Similar 
to previous findings, both studies showed a decrease of SM-B expression in tissues with 
PBOO when compared to sham controls which, in turn, was accompanied by an increase 
in SM-A expression.  Both also reported an increase in the SM1:SM2 ratio, although 
Mannikaruttu et al. (2005) showed more SM2 in control animals than Austin et al. 
(2004).  Rabbit studies also showed an increase in LC17b in PBOO animals.  In 
comparisons of different regions of the rabbit bladder, it was observed that the base 
region displayed a decrease in force and a more tonic-like contraction than the dome 
region.  By comparison, mouse studies showed a higher volume for optimal pressure and 
a decreased rate of pressure change in severe PBOO animals when compared to sham 
controls.  It was suggested from these studies that the SM-B isoform is a fast form of 
myosin and the SM-A isoform the slow form.  A later study agreed with this assessment 
(Basha et al. 2006), in which a higher percentage of SM-B in rat vaginal wall smooth 
muscle correlated with a higher Vmax of the myosin molecule, with SM1 and SM2 
showing no effect on the Vmax.  These studies continue to imply that SM-B is the 
isoform that denotes a more phasic characteristic to smooth muscle.  However, lower 
maximum force does not always correlate with increased Sm1 expression.    
A mouse model with a knockout of SM-B was developed (Babu et al. 2004) and 
the tissues of mesenteric arteries and aorta were examined.  The mesenteric vessels 
displayed higher force, stress, and time to 50% of peak contraction in knockout animals 
when compared to WT.  No change in tail isoform or light chain expression was seen in 
the mesenteric vessels of knockout mice compared to either WT or heterozygous mice.  
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Wild type (WT) animals did not express SM-B in aorta.  However, knockout animals still 
showed changes in the aorta muscle.  Shortening velocity was decreased, but force 
generation was increased.  K+ sensitivity was not changed in aorta, but sensitivity to 
phenylephrine was higher in the knockout animals.  In aorta, expression of Sm1, Sm2, 
and RLC were all unchanged in the knockout animals, but the LC17a:LC17b ratio was 
decreased due to a relative increase in LC17b.  The authors also observed an increase in 
calponin and a decrease in caldesmon in knockouts as well as an increase in ERK MAPK 
phosphorylation.  They concluded that the loss of SM-B in mesenteric arteries leads to 
adaptive changes in other areas of the circulatory system.  Changes in calponin, 
caldesmon, and MAPK activation could be evidence of those changes. 
 
Fluorescence resonance energy transfer (FRET) 
 The interaction of proteins is a very important aspect of cellular function.  This 
interaction can be measured in several ways including co-immunoprecipitation and yeast 
2 hybrid experiments.  Another way of determining protein interaction is by fluorescence 
resonance energy transfer (FRET).  FRET is one of the few tools for measuring distances 
and changes in distances on a nanometer scale (Selvin 2000).  If a sensitive enough 
detector is used (e.g. a charge coupled device (CCD)) FRET can be measured on a pixel 
by pixel basis (Selvin 2000).  This method utilizes fluorophores that are attached to the 
proteins in question.  This has typically been performed in solution using a 
spectrophotometer and purified proteins with fluorescent molecules directly attached.  
However, fluorescent microscopes can also be used.  FRET can extend the resolution of 
fluorescent microscopes and allow quantitative detection of protein-protein interactions 
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which is superior to standard colocalization measurements (Kenworthy 2001).  The 
fluorophores used must be chosen according to specific criteria.  One fluorophore, the 
donor, must have an emission spectrum that overlaps the excitation spectrum of the other, 
the acceptor.  If this criteria is met and the fluorophores are within 10 nm of each other 
(Jares-Erijman and Jovin 2003), the excitation of the donor molecule will result in 
emission energy being transferred to the acceptor effectively decreasing donor 
fluorescence.  The efficiency of this transfer can be calculated by an equation which 
views the efficiency as a function of the distance between the two fluorophores: 
 E=1/[1+(r/Ro)6] 
in which E stands for transfer efficiency, r is the distance separating the two fluorophores, 
and Ro is the Förster distance between donor and acceptor, typically 10-70 Å, and is a 
function of the spectral overlap of the donor emission and the acceptor excitation spectra.  
If the distance between donor and acceptor is >2 Ro, then FRET does not occur.  The 
Förster distance is defined in the Förster equation (Kekic et al. 1996):  E= Ro6/( Ro6+ R6), 
in which the Förster distance (Ro) is the distance between the donor and acceptor when E 
is 50%.  In this equation, R, the distance separating donor and acceptor probes, is defined 
by yet another equation: 
 R=9.78x103(Jn-4k2Qo)1/6. 
In this equation, J is the overlap integral between the emission spectrum of the donor and 
the absorption spectrum of the acceptor, n is the refractive index of the medium with a 
range of values between 1/3 and 1/5, k2 is the dipolar orientation factor having a range of 
0-4, but which is assumed to be 2/3 in most applications and Qo is the quantum yield of 
the donor  (Jares-Erijman and Jovin 2003). The equation we have adopted in our 
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laboratory is, E=1-(Fda/Fd), in which Fda is the fluorescence of the donor in the presence 
of the acceptor (i.e. before photobleaching of the acceptor) and Fd is the fluorescence of 
the donor in the absence of the acceptor (i.e. after photobleaching).  Hence the FRET 
method that we have employed utilizes the measurement of donor fluorescence 
quenching by the acceptor as an index of the cellular protein-protein interaction.  For this 
to work well, the donor fluorophore must remain stable and the acceptor fluorophore 
should photobleach readily (Kenworthy 2001).  Data acquisition requires acquiring an 
image of the activated donor before photobleaching of the acceptor, an image of the 
acceptor before photobleaching, photobleaching of the acceptor and viewing the acceptor 
to ensure it has been adequately photobleached, and then acquiring a second image of the 
donor.  An appropriate negative control to perform is that of only labeling the donor and 
performing the above steps to view how the donor molecule in affected by the 
photobleaching process.  A positive control that should be performed is placing both 
donor and acceptor labels on a single protein which should result in high transfer 
efficiency.  These experiments can be performed with antibody labels without direct 
labeling of the proteins being examined (Kenworthy 2001) as demonstrated in our 
laboratory (Dykes et al. 2003).  Our method of performing FRET can be considered novel 
because we not only use indirect labeling of the proteins in question, but we also are 
doing this labeling in order to examine protein-protein interaction within sections of 
smooth muscle tissue and isolated cells.   
FRET and other similar techniques have been used widely to measure 
intramolecular distances within the myosin protein and intermolecular distances between 
myosin and other contractile proteins as well as changes in those distances.  Distances 
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between the myosin heads bound to actin were found to be in the range of 6.0-6.3 nm 
(Ishiwata et al. 1997).  The distance between the catalytic domain and the regulatory light 
chain domain of the myosin head was measured and without ATP bound the distance was 
determined to be 73 Å (Burmeister Getz et al. 1998).  When ATP was bound to the active 
site the distance was increased.  The authors state that the distances they measured 
correlate well with crystal structure measurements.  Another group performed similar 
measurements and found that the distance between the catalytic and regulatory domain to 
be no longer than 85 Å (Palm et al. 1999).  Examining the myosin II of an amoeba with 
FRET enabled Suzuki et al. (1998) to confirm that the power stroke occurs with the 
release of Pi.  The hydrolyzation of ATP occurred during the recovery stroke (Suzuki et 
al. 1998).  FRET studies of Dictyostelium myosin II suggests that this myosin has two 
distinct prestroke states which are both induced by the binding of ADP and Pi, but not the 
binding of ATP (Shih et al. 2000).  The movement of myosin during the power stroke has 
also been examined with FRET.  Binding of actin to myosin caused a conformational 
change in the myosin protein.  The actin-dependent ADP swing caused an 18 Å change in 
distance between the 25/50 kDa loop in the catalytic domain and the RLC, which 
corresponds to a 23° swing of the light chain domain (Xiao et al. 2003).  Palm et al. 
(1999) found that during the power stroke RLC was reoriented in respect to ELC and 
could contribute 22 Å to the power stroke.  In scallop muscle fibers, it was found that the 
RLC domains moved closer together during contraction simulating a lever action (Lidke 
and Thomas 2002).  The distances between the RLCs during three muscle conditions 
were determined.  The distance during relaxation (85 Å) was greater than that of 
contracted (76.7 Å) and that of rigor (68 Å).  Some of the apparent differences in these 
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studies could be related to where exactly the fluorophores were attached to the molecules 
being studied.   
The light chain has been shown to move during the hydrolysis of ATP and the 
release of ADP and Pi during the power stroke (Reshetnyak and Andreev 2001; Mizukura 
and Maruta 2002).  Examination of the S1 fragment of skeletal muscle found changes in 
flexibility upon hydrolysis of ATP which the authors suggested could be the mechanism 
of the transfer of the energy of ATP hydrolysis from the ATP-binding domain to the lever 
arm (Bodis et al. 2003).   
Interaction of myosin with other molecules has also been examined.  It was 
determined that the binding of myosin displaced several tropomyosin molecules from F-
actin (Graceffa 1999).  Indeed the tropomyosin molecules were “rolled” uniformly on the 
F-actin by saturating S1 heads (Bacchiocchi et al. 2004).  Hence, FRET methodology has 
been widely employed and accepted as a valid tool in the study of myosin protein 
interactions. 
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Abstract 
 
AIM:  We examined the interaction of smooth muscle myosin with α-actin and β-actin 
isoforms during the contraction of A7r5 smooth muscle cells and rat aortic smooth 
muscle.  METHODS:  The techniques of confocal microscopy and fluorescence 
resonance energy transfer were utilized in examining A7r5 cells and rat aortic rings 
contracted with phorbol-12, 13-dibutyrate.  RESULTS:  Visual evaluation of confocal 
images of A7r5 smooth muscle cells contracted by phorbol-12, 13-dibutyrate indicated 
significant disassociation of myosin from α-actin but not β-actin.  Whole cell 
fluorescence resonance energy transfer analysis confirmed these observations (α-
actin/myosin, -67%; β-actin/myosin, -2%).  Time course studies further showed that α-
actin/myosin complex increased significantly (40%) within 1.5 minutes after the addition 
of phorbol-12, 13-dibutyrate and then declined as contraction progressed.  Fluorescence 
resonance energy transfer analysis of rat aortic rings at different intervals of contraction 
indicated significant increases in α-actin/myosin at the initiation (79%) and plateau 
(67%) in force development but not during the intermediate period of slowly developing 
tension (-4%).  By comparison, β-actin/myosin complex was unchanged except during 
slow force development where the association was significantly decreased (-30%).  
Similar to α-actin/myosin, Alexa 488-phalloidin staining fluorescence indicated 
increased tissue F-actin content at initiation (21%) and the plateau (62%) in force.  
Fluorescence resonance energy transfer images indicated the development of thickened 
cables and patches of α-actin/myosin in tissue throughout the interval of contraction.  
CONCLUSION:  The results provide direct evidence of dynamic remodeling of the 
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contractile protein during vascular smooth muscle contraction and suggest that 
fluorescence resonance energy transfer analysis may be a powerful tool for assessment of 
tissue protein-protein associations. 
 
Introduction 
 
A number of the contractile properties exhibited by smooth muscle are not readily 
explained by unmodified sliding filament theory.  For example, smooth muscle has the 
ability to slowly develop force and then to sustain maximal tension for extended intervals 
at low energy cost (22).  Moreover, there is evidence suggesting that force development 
and sustained tension (6) as well as velocity of shortening (20) are disassociated from 
myosin ATPase activity (32) in smooth muscle.  Hence, there is growing recognition that 
mechanisms exist to modify the contractile properties of smooth muscle from that 
predicted solely on the basis of actin/myosin interaction within a static sarcomere 
arrangement. 
  
One hypothesis gaining interest is that the contractile apparatus remodels in response to 
cell loading and during force development with cell shortening.  Based on studies of 
isolated cells in which it was demonstrated that the length-tension relationship was 
altered by changing the initial length at which the cells were activated, Harris and 
Warshaw (1991) first suggested a disassociation of cell length and contractile element 
length.  Gunst et al. (1993) subsequently showed that the velocity of shortening decreased 
as the tissue was activated at increasing lengths suggesting their results were consistent 
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with an earlier hypothesis (13) that decreased velocity could reflect an internal load 
created by compression of the cytoskeleton.  They further suggested (11) that the inverse 
relationship between tissue length and velocity of shortening could be due to 
reorganization of the cytoskeleton serving to optimize contractile responses at each 
length.  In a similar vein, Shen et al. (1997) concluded that the depression of force seen 
during oscillation of smooth muscle could be due to resetting of contractile element 
length due to stretch.  Based on the observation that cytochalasin inhibition of actin 
polymerization blocked slow force development in rat aortic smooth muscle, our 
laboratory proposed that dynamic remodeling within the actin cytoskeleton was 
obligatory for this mode of contraction (30).  This conclusion has been supported by the 
finding that inhibition of actin polymerization depresses force development without 
affecting myosin light chain phosphorylation, suggesting that actin remodeling 
contributes directly to force development (19). 
 
It has also been suggested that remodeling of myosin could play a primary role in 
determining the contractile properties of smooth muscle by increasing the length of 
individual filaments and/or the number of contractile units in series (8, 23).  The 
proposed series-to-parallel transition in myosin thick filament arrangement could 
potentially explain potentiation of isometric force and the inverse relationship between 
force and velocity of shortening (24). 
 
Although there is increasing acceptance of the importance of cytoskeletal remodeling in 
smooth muscle contraction, the exact nature of the reorganization and manner in which 
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this impacts on contractility remains a matter of speculation.  A number of studies have 
reported evidence of actin polymerization in tissues contracted with acetycholine (19, 
26), histamine (1) and norepinephrine (27).  In addition, there is evidence to suggest that 
the number of myosin filaments is increased in contracted anococcygeus muscle (31).  
Studies of A7r5 smooth muscle cells contracted with phorbol esters further suggests that 
contractile remodeling may be unexpectedly complex.  Initial findings indicate that α- 
and β-actin, the dominant isoforms in these cells, remodel differently during contraction 
(10, 18) suggesting they could be subject to different regulatory influence.  In addition, 
myosin was observed to undergo extensive relocalization in association with α-actin 
during phorbol-induced contraction of these cells (9).  However, it is not certain to what 
extent these findings in cultured cells apply to preloaded, highly differentiated smooth 
muscle cells within their tissue matrix.  In the present study we have utilized confocal 
microscopy and fluorescence resonance energy transfer (FRET) analysis to compare 
actin/myosin association in A7r5 cells and rat aortic tissue at different time points during 
contraction.  The results support actin isoform specific changes in association with 
myosin and alteration of actin/myosin structure during contraction. 
 
Methods 
 
Animals.    All procedures were performed in accordance with the Guide for the Care 
and Use of Laboratory Animals as approved by the Council of the American 
Physiological Society and the Animal Use Review Board of Marshall University.  Male 
12 week-old Sprague Dawley rats were housed on wood chip bedding in rooms 
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maintained at 23 ± 2°C with a 12h light cycle.  Purina Rat Chow and tap water were 
freely available. 
 
Tissue Preparation.  Rats were anesthetized with a ketamine-xylazine mixture (21:9 mg 
kg-1) and the thoracic aorta was surgically removed into buffer, cleaned of adherent 
tissue, and cut into 0.3 cm rings.  Tissues were denuded of endothelium and then 
mounted under 5.0g of passive tension in glass organ baths containing Krebs buffer [(in 
mM) 118 NaCl, 4.7 KC1, 1.5 CaCl2, 25 NaHCO3 1.1 MgCl2, 1.2 KH2PO4, and 5.6 
glucose; pH 7.4] maintained at 37°C and aerated with 5% CO2 in O2.  The tissues were 
equilibrated for a minimum of 2h before contraction by addition of 10-7M phorbol-12, 13-
dibutyrate (PDBu).  Isometric tension was measured using a grass FT03 force-
displacement transducer and a Grass model 7D polygraph.  Rings removed from the bath 
at selected intervals of contraction (Fig. 1) were cut longitudinally, placed adventitia 
down on aluminum foil and snap frozen in liquid nitrogen.  Samples were maintained at -
70°C until sectioned. 
 
Cell Culture.  A7r5 smooth muscle cells derived from embryonic rat aorta and shown to 
maintain the ability to contract to phorbol esters (21, 10), were obtained from American 
Type Culture Collection (Manasass, VA).  Cells were plated on 75 cm2 flasks and grown 
to approximately 80% confluence at 37°C in a humidified atmosphere of 5% CO2 in air.  
The cells were maintained in Dulbecco’s modified Eagles medium (DMEM) 
supplemented with 10% fetal calf serum, 100 units ml-1 penicillin G, and 100 µg ml-1 
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streptomycin.  Media was changed every other day and cells were passaged at least once 
a week. 
 
 
Confocal Microscopy.  Cells were seeded onto glass coverslips, placed in 6 well culture 
plates and returned to the incubator to allow for attachment and spreading.  After 
treatment with PDBu (10-7 M) the cells were immediately fixed and permeabilized by 
addition of ice-cold acetone for 1.0 minute.  The cells were then washed several times 
with phosphate-buffered saline (PBS) containing 0.5% TWEEN-20 (PBS-T), pH 7.5, 
followed by a 60 minute incubation in blocking solution containing 5% nonfat dry milk 
in PBS.  Aortic rings from individual rats were selected for study at the onset of PDBu-
induced force development (0.3g tension), approximately midway through the 
contraction (2.5g tension), and 15 minutes after the plateau in tension (Fig. 1).  Tissues 
were sectioned at 8 µm longitudinally on an IEC cryotome and placed on poly-L-lysine 
coated slides.  Sections were then fixed and permeablized by addition of ice-cold acetone 
for 1.0 minute.  The slides were rinsed (3X) with PBS-T and preblocked with 5% nonfat 
dry milk in PBS.  Cell and tissue samples were stained for myosin by incubation with a 
monoclonal, clone C5C.S2 pan-anti-myosin IgM primary antibody (Covance, Berkeley, 
CA) followed by an anti-IgM Alexa 546 secondary antibody (Molecular Probes, Eugene, 
OR).  α-Actin and β-actin were visualized using monoclonal anti-α-smooth muscle actin, 
clone 1A4 (IgG2a) and anti-β-actin, clone AC-15 (IgG1) primary antibodies (Sigma, 
Saint Louis, MO), respectively, followed by Alexa 488 anti-IgG secondary antibody 
(Molecular Probes).  In many experiments, tissues were also stained with TO-PRO-3 
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iodide (Molecular Probes) to enable visualization of the cell nucleus in combination with 
FRET images.  Cells were viewed at 600X magnification and tissue sections were viewed 
at 1000x.  The numerical aperture of the objective was 1.4.  The thickness of the section 
analyzed was 0.5 µm.  
 
To evaluate F-actin content, tissue sections from each group were stained with phalloidin 
conjugated with an Alexa 488 fluorophore (Molecular Probes, Eugene, OR).  Sections 
from all groups were imaged at constant confocal settings and the fluorescence plot was 
obtained using Image J (NIH) software.  The area under the curve was determined using 
PeakFit (Systat Software, Inc., Richmond, CA) and the fluorescence calculated per unit 
area surveyed. 
 
FRET analysis.  In the present study, we utilized the approach of measuring donor 
molecule quenching in the presence of acceptor as an index of FRET (reviewed in 16).  
This approach to FRET evaluation is amenable to immunostaining and confocal imaging 
of fixed biological samples.  It must be noted, however, that the method as presently 
employed assumes that such factors as the absorption coefficient of the acceptor, the 
quantum yield of the donor, relative antibody binding affinity and the relative orientation 
of donor/acceptor antibody complexes, remain constant between treatment groups.  Cell 
and tissue samples were imaged with a Nikon Diaphot Microscope and confocal 
microscopy performed with a BioRad Model 1024 scanning system with a krypton/argon 
laser.  Within a FRET system two fluorophores with overlapping emission and excitation 
spectra are utilized.  Here actin isoforms were labeled with Alexa 488 (excitation, 488 
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nm; emission, 520 nm) and served as the donor component of the system.  Myosin was 
labeled with Alexa 546 (excitation, 546 nm; emission, 580 nm) and served as the 
acceptor component.  The donor molecule (α- or β-actin, Alexa 488) was directly excited 
and the resulting emission was obtained with a 522 DF32 band pass filter.  However, a 
portion of the energy of emission was not released as light but was transferred to 
neighboring Alexa 546 fluorophore resulting in emission which was captured on a second 
channel with an HQ 598/40 band-pass filter.  Subsequently, the image was excited at the 
568 nm laser line at 100% power to photobleach the acceptor molecule (myosin) and a 
second image of the cell or tissue was acquired again at the 488 nm laser line excitation 
with the multichannel filter set to obtain actin fluorescence (522 DF32) and to verify the 
absence of myosin label Alexa 546 emission (HQ 598/40).  An intensity profile was 
generated for each sample (Image J Software, NIH) and the resulting plot was analyzed 
with Peakfit V4.11 software (SPSS Science, Richmond, CA) to obtain the area under the 
curve.  The values were then used to calculate the percent increase in fluorescence 
emission after photobleaching.   Resonance energy transfer can only occur if the donor 
and acceptor molecules are close enough to each other for the transfer to occur 
efficiently.  Hence, the resulting values were analyzed in comparisons of control and 
PDBu-treated A7r5 cells and aortic tissue samples as an index of the association between 
actin and myosin during PDBu-induced contraction. 
 
In addition to the evaluation of experimental samples, FRET analysis of A7r5 cells was 
conducted in two control conditions.  In an initial experiment, FRET analysis of α-
actin/myosin association was performed in the absence of anti-α smooth muscle actin 
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clone 1A4 primary antibody.  This negative control tested for the magnitude of effect of 
non-specific binding of the donor Alexa 488 labeled secondary antibody in its 
contribution to the increase in fluorescence intensity after photobleaching of the Alexa 
546 labeled myosin.  In a second experiment, unstimulated and PDBu-treated cells were 
stained only for myosin using the monoclonal, clone C5C.S2 pan anti-myosin primary 
antibody.  This was followed by incubation with a 1:1 mixture of mouse anti-IgM 
antibodies conjugated to Alexa 488 or Alexa 546 fluorophores.  Because the primary 
antibody binding epitope is the S2 head region of myosin, it was expected that the FRET 
index of increased fluorescence after acceptor fluorophore photobleaching would not be 
altered by PDBu treatment as occurred with actin/myosin association. 
 
Statistics.  Differences in the index of actin/myosin association were analyzed by 
ANOVA followed by Student’s t-test (Sigma Stat 2.03, SPSS Science).  Differences were 
considered significant if P < 0.05 in all cases.  Data are presented as means ±  SEM 
throughout the text. 
 
Results 
 
A7r5 Smooth Muscle Cells.  Figure 2 shows control and PDBu-treated (10-7 M) cells 
with dual staining for α-actin and myosin.  Similar to previous findings (10), 
colocalization imaging indicated myosin association with α-actin stress fibers in 
unstimulated control cells.  PDBu stimulation resulted in a loss of α-actin stress fibers 
with relocation of α-actin at podosomes in the cell periphery.  Myosin was observed to be 
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associated with α-actin in podosomes and in the remaining stress fibers but also showed 
diffuse staining in the perinuclear region, suggesting substantial disassociation of myosin 
from α-actin in the contracted cell.  Figure 3 shows FRET analysis of the same cells 
including fluorescence before and after acceptor (myosin) photobleaching.  In addition to 
enabling the calculation of an index of α-actin/myosin association (Table 1A), the 
difference between these two images may provide a high resolution method for imaging 
specific sites of protein interaction not completely clear from colocalization images.  For 
example, FRET images show clearly the intermittent nature of α-actin/myosin 
association in stress fibers and indicate strong α-actin/myosin association on the cytosolic 
side of podosomes (Fig. 3). 
 
Unlike α-actin, β-actin remained in stress fibers in PDBu-treated cells (Fig. 4).  Myosin 
appeared to be colocalized with β-actin stress fibers as well as perinuclear structure not 
observed in α-actin stained cells.  FRET analysis indicated β-actin/myosin association in 
stress fibers but further suggested a diffuse, network-like arrangement of β-actin/myosin 
structure in some cells (Fig. 5). 
 
FRET analysis yielded significant indices of myosin association with α-actin (73.3 ± 6.0) 
and β-actin (74.5 ± 5.2) in control A7r5 cells (Table 1A).  Consistent with visual 
evaluations of colocalization images suggesting myosin disassociation at near completion 
of cell contraction, the index of myosin association with α-actin decreased by 
approximately 70% in PDBu-treated cells (Table 1A).  By comparison, the FRET index 
of myosin association with β-actin was unchanged in PDBu-treated cells.  A detailed 
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FRET evaluation of the time course of α-actin/myosin association further indicated a 
significant increase in the interaction of these proteins within the 5.0 min interval 
following the addition of PDBu which then declined with cell contraction (Table 1B).  
FRET analysis of α-actin/myosin association in the absence of anti-α-smooth muscle 
actin primary antibody indicated insignificant non-specific binding of donor Alexa 488 
labeled secondary antibody (<1% control).  As expected the increase in Alexa 488 
fluorophore fluorescence after photobleaching of the acceptor Alexa 546 fluorophore was 
not different between control (17.8 ± 3.4%) and PDBu-stimulated (22.5 ± 1.7%) cells.  
Taken together, the results with A7r5 cells suggest a highly dynamic remodeling of the 
actin/myosin contractile protein during contraction.  They further suggest that FRET 
analysis is a valuable tool in determining cell protein-protein associations. 
 
Aortic Vascular Smooth Muscle.  Dual staining with phalloidin and TO-PRO-3 iodide 
shows the parallel and densely packed arrangement of vascular smooth muscle cells (Fig. 
6).  This figure emphasizes the differences in cell plane of section and lack of detailed 
structure which make difficult the interpretation of images from tissue sections.  
Actin/myosin colocalization imaging (Fig. 7) shows the confusion of structure typically 
obtained with immunostaining of these proteins in tissue, while indicating significant 
colocalization of the two proteins.  FRET analysis greatly simplified the tissue images of 
actin/myosin structure (Fig. 8), and indicated that α-actin/myosin complex was increased 
at the beginning (79%) and at the plateau (67%) in force development, but was 
unchanged from control midway through the PDBu-induced contraction (Table 2).  By 
comparison, β-actin/myosin association was not significantly different from controls 
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except at mid-contraction where an approximate 30% decrease was recorded.  The results 
suggest extensive isoform specific remodeling of the actin/myosin contractile protein in 
contracting vascular smooth muscle tissue. 
 
Evaluation of actin/myosin structural changes in intact tissues remains problematic.  The 
small cell size, variance in cell orientation in the plane of sectioning, difficulty in 
achieving correct orientation of tissues for sectioning, and the relatively low 
magnification of confocal microscopy each contribute to the random nature of 
actin/myosin structural organization seen in tissue.  Nevertheless, we report one change 
in α-actin/myosin consistently observed in contracting but not control tissue.  Notable at 
each stage of contraction was the coalescence of α-actin and myosin, which when viewed 
in relation to nuclei, appeared as thickened cables or patches (Fig. 9).  We estimate that 
cable-like structures in tissues range at 0.6 to 1.0 µm in diameter and are comparable in 
size to stress fibers observed in A7r5 cells (1.0-2.2 µm) 
 
Quantitation of phalloidin staining fluorescence suggested that the F-actin content of 
tissue slightly increased (21%) at the beginning of force development and was 
significantly elevated (62%) at the plateau in tension (Table 3).  F-actin was reduced (-
17%) midway through the contraction but this was not significantly different from the 
control value. 
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Figures 
 
 
 
 
 
Figure 1. Time intervals selected for FRET analysis of rat aortic smooth muscle.  Aortic 
rings were mounted in glass organ baths at a preload of 5.0g and equilibrated for 2 hours.  
They were then contracted by the addition of 10-7 M phorbol 12, 13 dibutyrate (PDBu) 
and removed at time 0 (A), at the start of force development (B), approximately midway 
through the contraction (C), and at 15 minutes after the plateau in tension (D).  The 
tissues were then frozen in liquid nitrogen for sectioning.  A set of aortic segments 
obtained at each interval was taken from an individual animal. 
  
65
65
 
 
 
Figure 2. Dual immunostaining of α-actin and myosin in unstimulated (Control) and 
PDBu-activated A7r5 cells.  At 20 minutes after PDBu (10-7 M) addition, cells were fixed 
with acetone and prepared for confocal imaging.  α-Actin was visualized with a 
monoclonal anti-α-smooth muscle actin, clone 1A4 antibody.  Myosin was visualized 
with a monoclonal, clone C5C.52 pan-anti-myosin antibody.  Yellow color indicates 
colocalization of the two proteins.  The white bar indicates 20 µm. 
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Figure 3. FRET analysis of α-actin/myosin complex in control and PDBu-activated 
A7r5 cells shown in Figure 2.  α-Actin was labeled with Alexa Fluor 488 and served as 
the donor component.  Myosin was labeled with Alexa Fluor 546 and served as the 
acceptor component.  Images show α-actin fluorescence before and after photobleaching 
of the acceptor fluorophore.  The difference in fluorescence between the before and after 
images was determined using Paint Shop Pro software.  Arrows point to stress fibers in 
control cells showing clear intermittent α-actin/myosin association and to indicate the 
localization of α-actin/myosin complex on the cytosolic side of podosomes. 
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Figure 4. Dual immunostaining of β-actin and myosin in control and PDBu-activated 
A7r5 cells.  Twenty minutes after the addition of PDBu, cells were fixed with acetone 
and prepared for confocal microscopy.  β-Actin was visualized with a monoclonal anti-β-
actin, clone AC-15 antibody.  Myosin was visualized with a monoclonal, clone C5C.52 
pan-anti-myosin antibody.  Yellow color indicates colocalization of the two proteins.  
The bar in the lower right panel indicates 20 µm. 
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Figure 5. FRET analysis of β-actin/myosin complex in control and PDBu-activated 
A7r5 cells shown in Figure 4.  β-Actin was labeled with Alexa Fluor 488 and served as 
the donor component.  Myosin was labeled with Alexa Fluor 546 and served as the 
acceptor component of the system.  Images show β-actin fluorescence before and after 
photobleaching of the acceptor fluorophore.  The difference in fluorescence was then 
determined using Paint Shop Pro software.   
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Figure 6. Rat aortic smooth muscle dual stained with phalloidin (F-actin) and TO-PRO-
3 iodide (nuclei) to demonstrate the parallel and densely packed arrangement of cells in 
tissue.  Note the variance of cells within the plane of section and the lack of intracellular 
structural detail typically seen in these sections.  The bar at the lower right of the panel 
indicates 10 µm. 
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Figure 7. Dual staining of a control tissue section for α-actin and myosin.  Sections 
were immunostained for α-actin using a monoclonal anti-α-smooth muscle actin, clone 
1A4 antibody while myosin was visualized using a monoclonal, clone C5C.52 pan-anti-
myosin antibody.  Yellow color indicates α-actin and myosin colocalization.  The white 
bar in the lower right hand panel indicates 10 µm.  The image emphasizes the confusion 
of structure obtained with colocalization staining of tissue sections. 
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Figure 8. FRET analysis of α-actin/myosin in aortic tissue sections shown in Figure 7.  
α-Actin was labeled with Alexa Fluor 488 and served as the donor component.  Myosin 
was labeled with Alexa Fluor 546 and served as the acceptor component.  Images show 
α-actin fluorescence before and after photobleaching of the acceptor fluorophore.  The 
difference between the before and after images was then determined using Paint Shop Pro 
software.  This panel demonstrates the simplification of the image engendered by 
visualization of only α-actin/myosin complex. 
  
72
72
 
Figure 9. FRET images showing α-actin/myosin structure in relation to cell nuclei at the 
various intervals during contraction.  Tissue sections were immunostained for FRET 
analysis as indicated above and were additionally stained with TO-PRO-3 iodide to 
visualize cell nuclei (blue).  Differences between before and after images were obtained 
with Paint Shop Pro and merged with nuclear stain images.  The images are typical of 
sections showing limited structure in controls with the development of thick α-
actin/myosin cables and patches at each stage of contraction examined. 
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Tables 
 
Table 1.  Fluorescence resonance energy transfer (FRET) analysis of the association of 
myosin with α- and β-actin in Control and PDBu-stimulated A7r5 cells.  A) The index of 
association between actin isoforms and myosin for control cells and those at an advanced 
stage of contraction (20 min.).  B) The association index of α-actin and myosin at 
selected time intervals after PDBu addition with data presented as percentage of the 
control value.  Myosin was visualized using a monoclonal, clone C5C.52 pan-anti-
myosin antibody.  α-Actin and β-actin were visualized with monoclonal anti-α smooth 
muscle actin clone 1A4 and anti-β-actin clone AC-15 antibodies, respectively.  Values 
represent the average of a minimum of 10 cells. 
 
A. FRET Association Index  
 
Treatment α-actin β-actin 
   
Control 73.3 ± 6.0 74.5 ± 5.2 
PDBu (20 min.) 24.4 ± 2.8* 73.0 ± 4.5 
   
 
 
B. Time course 
 
Time, min. α-Actin/Myosin Association 
Index+ 
  
0 100.0 ± 8.2 
1.5   139.8 ± 8.2* 
5   133.4 ± 9.3* 
10 112.1 ± 8.0 
20     33.2 ± 3.8* 
 
+Data presented as % of Control.  An asterisk (*) indicates significant difference from the 
control value, P < 0.05 or greater. 
  
74
74
 
Table 2.  FRET analysis of the association of myosin with α- and β-actin in rat aortic 
smooth muscle.  Aortic rings were mounted in glass organ baths and contracted by the 
addition of 10-7 M PDBu.  Tissue were removed for analysis before PDBu addition 
(Control), at the first indication of force development (Start), approximately midway 
through the contraction, and well after the establishment of the plateau in force 
development.  Values represent the average of 10 determinations from different tissues 
and are presented as percent of control. 
 
 
 
Sample Time α-actin β-actin 
   
    Control 100.0 ± 15.0 100.0 ± 8.7 
    Start   179.2 ± 18.8*   139.0 ± 13.1 
    Midway   96.2 ± 15.0     70.1 ± 6.1* 
    Plateau   167.9 ± 11.3*     94.7 ± 10.5 
   
 
An asterisk (*) indicates a significant difference from the control value, P < 0.05 or 
better. 
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Table 3.  F-actin content of tissue sections obtained from aortic segments before 
contraction with 10-7 M PDBu (Control), at the beginning of force development, 
approximately midway through the contraction, and after the plateau in force 
development.  Tissue sections were stained with phalloidin and fluorescence obtained at 
constant confocal settings for all tissue groups.  Values represent the average of 8 to 10 
sections from individual vessels and are presented in ratio to the control value. 
 
 
 
 
Treatment Fluorescence/Unit Area 
  
  Control 1.00 ± 0.07 
  Start 1.21 ± 0.11 
  Midway 0.83 ± 0.08 
  Plateau   1.62 ± 0.18* 
  
 
An asterisk indicates significant difference from the Control value, P < 0.05 or better. 
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Discussion 
 
Phorbol esters, as analogues of diacylglycerol, act through PKC to induce a robust, 
slowly developed contraction in vascular smooth muscle.  In A7r5 smooth muscle cells, 
phorbol 12, 13 dibutyrate (PDBu) has been demonstrated to induce contraction in the 
absence of an increase in [Ca2+]i and is thought to act by both calcium-dependent and 
independent mechanisms (21).  At advanced stages of the PDBu contraction there is a 
loss in α-actin stress fibers (10) as α-actin remodels to podosomes at the cell periphery 
(10, 12).  In contrast, β-actin remained in stress fibers during the interval of α-actin 
reorganization.  Most surprising, confocal images suggest decreased actin/myosin 
association in contracting A7r5 cells during podosome formation (9). 
 
Whole cell FRET analysis has been successfully used to evaluate microtubule-PKC-α 
complexes in PDBu-contracted A7r5 cells (7).  Because the donor/acceptor proteins must 
be within 100 angstroms distance from each other for efficient energy transfer (5, 16) this 
technique provides a measure of protein-protein distances compatible with molecular 
interaction.  The present results using FRET analysis indicate dynamic changes in the α-
actin/myosin contractile protein throughout the course of PDBu-induced A7r5 cell 
contraction (Table 1).  Associated α-actin/myosin increased significantly at the initiation 
of contraction but declined to an estimated 70% loss in the contractile protein during the 
interval of visible loss in α-actin stress fibers and podosome formation.  Furthermore, 
FRET images provided clear resolution of α-actin/myosin structure, showing the 
intermittent arrangement of the complex in stress fibers and that α-actin/myosin 
  
77
77
association was primarily localized on the cytosolic side of podosomes (Fig. 3).  By 
comparison, FRET analysis indicated β-actin/myosin association remained stable during 
the interval of α-actin/myosin disassociation and showed well defined perinuclear 
structure not observed in α-actin/myosin images.  The results confirm earlier conclusions 
regarding the isoform-specific remodeling of the cytoskeleton in PDBu-contracted A7r5 
cells and indicate the potential use of FRET analysis in whole cell evaluation of protein-
protein associations. 
 
In recent work, Kuo et al. (2003) have correlated myosin filament density with isometric 
force, shortening velocity, power output, and the ATPase rate in tracheal smooth muscle 
adapted to different lengths prior to contraction with acetylcholine.  Based on findings of 
increased myosin filament density and changes in contractile function at increased tissue 
preload, they proposed cytoskeletal remodeling to increase actin/myosin units in series at 
increased tissue length.  Consistent with this model, a number of reports have indicated 
increased tissue F-actin content in contracted smooth muscle (15, 19, 1, 27, 28, 29).  The 
present results support previous conclusions of increased F-actin and actin/myosin 
association in vascular smooth muscle contracted by PDBu.  However, our findings 
further suggest that the contractile cytoskeleton undergoes variable remodeling during the 
course of contraction.  We report evidence for both increased F-actin and α-actin/myosin 
association at the initiation and the plateau in force development but not in the 
intermediate interval of force development.  One explanation is that slow force 
development represents a period of significant reorganization of the contractile apparatus 
with activity similar to the previously proposed “asynchronous” remodeling (2, 18) in 
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which a portion of the cytoskeleton remodels to sustain force development while the 
remainder serves to preserve tension gains.  Similar to findings in A7r5 cells (10, 18) 
tissue smooth muscle showed a dichotomy in α-versus β-actin association with myosin 
during the interval of contraction (Table 2).  The β-actin/myosin complex appeared less 
labile than that of α-actin but was observed to decrease significantly midway through the 
contraction further suggesting significant remodeling during shortening and re-alignment 
of the contractile apparatus. 
 
Probably due to a number of technical difficulties including the relatively low 
magnification power available with confocal microscopy, FRET images of control tissue 
sections revealed little detail of cellular actin/myosin structure.  However, the formation 
of thickened patches and cable-like α-actin/myosin structures were observed in 
contracted tissue (Fig. 9).  These structures argue against homogeneous distribution of 
contractile protein in the contracting cell, a finding consistent with earlier observations of 
myosin segregation to the periphery of cross-sectional profiles in stretched guinea pig 
taenia coli smooth muscle (4).  On the other hand, heterogenous distribution might be 
reasonably expected in cells undergoing cytoskeletal remodeling in response to changes 
in cytoskeletal strain resulting from internal tension development as well as that imposed 
by adjacent cell activity. 
 
In summary, the results show that in unloaded A7r5 cells, PDBu-induced contraction 
resulted in isoform-specific remodeling of the actin cytoskeleton with increased α-
actin/myosin structure at the start of contraction followed by loss of α-actin stress fibers 
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and myosin disassociation with advanced contraction.  In preload aortic segments, PDBu-
induced contraction resulted in isoform-specific changes in association with myosin.  
Hence, the remodeling characteristics of both cells and tissues suggest that the regulation 
and potentially the contractile function of these isoforms may differ.  Both the tissue F-
actin content and α-actin/myosin complex increased at the initiation of force 
development and during the plateau phase of tension maintenance but was at the control 
level during the interval of slowly developing force midway through contraction.  The 
work of Chrzanowska-Wadnicka and Burridge (1996) has provided compelling evidence 
that cytoskeletal strain is obligatory for stress fiber formation.  Based on their findings, 
the results of the present study may reflect predominantly actin/myosin polymerization in 
response to strain on established contractile protein during the initiation and plateau in 
force development.  However, midway through the contraction, the internal shortening of 
the contractile apparatus and development of external strain due to adjacent cell activity 
would be expected to alter vectors of force imposed on the cytoskeleton.  Hence, it may 
be reasonable to speculate that during this interval, concurrent contractile protein 
polymerization/depolymerization serves to constantly address changes of internal strain 
with realignment of the contractile cytoskeleton for optimal force development. 
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Abstract 
Actin and smooth muscle myosin have several different isoforms.  How these different 
isoforms interact and remodel during smooth muscle contraction is still unknown.  We 
used fluorescence resonance energy transfer (FRET) and co-immunoprecipitation to 
examine the interactions of the myosin tail isoforms SM1 and SM2 with α-actin and β-
actin in an A7r5 embryonic rat aorta smooth muscle cell model and in intact adult rat 
aorta tissue.  Confocal images of A7r5 cells showed little colocalization of SM2 or SM1 
with either actin isoform in either control cells or cells contracted with phorbol-12, 13-
dibutyrate.  Although FRET transfer efficiencies were higher for SM1, no significant 
difference was seen between control and contracted cells.  In tissue, higher colocalization 
was visible between the myosin isoforms and the actin isoforms.  However, FRET 
showed slight changes in myosin association with α-actin during contraction with a 
significant decrease seen with SM1 and α-actin interaction at the midpoint of contraction.  
Both myosin isoforms showed significant decreases in their interaction with β-actin 
between control and most time points of contraction.  Co-immunoprecipitation of tissue 
lysate showed the same trends as the results of FRET experiments.  These results suggest 
that SM1 and SM2 interact differently with α-actin and β-actin during contraction and 
that these two actin isoforms remodel in different ways during contraction with phorbol.  
Finally, FRET results were confirmed by co-immunoprecipitation suggesting that this 
technique can be used in tissue sections to accurately determine protein-protein 
interactions.  
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Introduction 
 
Smooth muscle contraction is an integral part of mammalian physiology.  However, the 
mechanisms underlying force development in this muscle type are still not completely 
known.  The lack of a skeletal muscle-like sarcomere has caused much debate over how 
the contractile apparatus forms and functions.  One hypothesis put forth is that controlled 
cytoskeletal remodeling could maintain the contractile apparatus at optimal mechanical 
advantage and serve to maintain contraction with little energy expenditure (Paul 1983).  
Several papers have been published discussing the potential role of both actin remodeling 
(Fultz et al. 2000; Herrera et al. 2004; Brown et al. 2006) and myosin remodeling 
(Herrera et al. 2002; Fultz and Wright 2003) in smooth muscle contraction.   
 
Two major actin isoforms have been reported to occur in the smooth muscle cell.  α-
Actin has been used as a marker for smooth muscle and is thought to be a major 
component of the contractile apparatus, while β-actin is proposed to serve a role in 
cytoskeletal structure (North et al. 1994).  Both isoforms have been found to remodel in 
distinctly different ways when the A7r5 embryonic smooth muscle cell is caused to 
contract by phorbol-12, 13-dibutyrate (PDBu) (Fultz et al. 2000; Brown et al. 2006).  β-
Actin has been found to remain in stress fibers at lower PDBu concentrations (<10-7 M)  
as α-actin is seen to relocate to structures known as podosomes at these lower 
concentrations.  At higher concentrations of PDBu, β-actin has been reported to also 
migrate to the podosomes (Brown et al. 2006).   
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Smooth muscle myosin is a very diverse molecule with several isoforms found within 
smooth muscle (White et al. 1998).  The different carboxy isoforms were first reported by 
Rovner et al. (1986), based on the discovery of two myosin heavy chains on a denaturing 
polyacrylamide gel using protein extracts from several smooth muscle tissues.  They first 
used the terms Sm1 and Sm2 to denote the heavier (204kDa) isoform and the lighter 
(200kDa) isoform, respectively.  These isoforms are formed by alternative splicing of the 
same myosin gene (Babij and Periasamy 1989; Nagai et al. 1989) resulting in Sm1, with 
43 unique amino acids at its carboxyl end and another, Sm2, with 9 unique amino acids at 
the carboxyl end.  Rovner et al. (1986) noted a 1:1 ratio of Sm1 to Sm2 but could not 
determine if Sm1 and Sm2 formed homodimers or heterodimers.  Subsequently (Kelley 
et al. 1992), it was determined that Sm1 and Sm2 form homodimers dominantly, but that 
under certain conditions thick filaments may contain both Sm1 and Sm2 myosin 
molecules (Rovner et al. 2002).  The difference in function between the two myosin tail 
isoforms is not well understood.   
 
In addition to the tail isoforms, the myosin heavy chain has other isoforms (White et al. 
1998; Low et al. 1999) generated by alternative splicing in the head region leading to a 
seven amino acid insert near the actin-activated Mg2+-ATPase (Babij et al. 1991; Babij 
1993) and it is this isoform that is thought to convey faster myosin enzymatic activity 
(Kelley et al. 1993; DiSanto et al. 1997; Rovner et al. 1997; Austin et al. 2004).  It is now 
generally believed that the head isoforms determine enzymatic differences; whereas the 
tail isoforms play a role in structural differences.  Cells from rat arteries were found to 
have differing final cell length after contraction which correlated significantly with the 
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Sm2/Sm1 ratio with length decreasing as the amount of Sm2 increased (Meer and 
Eddinger 1997).  Sm1 and Sm2 show differences in filament formation (Rovner et al. 
2002) suggesting that, similar to actin, the myosin isoforms could remodel differently in 
contracting cells. 
 
We examined the association of myosin tail isoforms with α-actin and β-actin using 
fluorescence resonance energy transfer (FRET) and co-immunoprecipitation.  The results 
show that myosin isoforms undergo changes in association with actin during the interval 
of contraction studied suggesting the force generating activity due to actin-myosin 
interaction declines in the later stages of contraction as the tissue approaches a plateau in 
tension. 
 
 
 
 
Methods 
 
Animals.    All procedures were performed in accordance with the Guide for the Care 
and Use of Laboratory Animals as approved by the Council of the American 
Physiological Society and the Animal Use Review Board of Marshall University.  Male 
12 week-old Sprague Dawley rats were housed on wood chip bedding in rooms 
maintained at 23 ± 2°C with a 12h light cycle.  Purina Rat Chow and tap water were 
freely available. 
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Tissue preparation.  Rats were anesthetized with a ketamine-xylazine mixture (21:9 mg 
kg-1) and the thoracic aorta was surgically removed into buffer, cleaned of adherent 
tissue, and cut into 0.3 cm rings.  Tissues were denuded of endothelium and then 
mounted under 5.0g of passive tension in glass organ baths containing Krebs buffer [(in 
mM) 118 NaCl, 4.7 KC1, 1.5 CaCl2, 25 NaHCO3 1.1 MgCl2, 1.2 KH2PO4, and 5.6 
glucose; pH 7.4] maintained at 37°C and aerated with 5% CO2 in O2.  The tissues were 
equilibrated for a minimum of 2h before contraction by addition of 10-7M phorbol-12, 13-
dibutyrate (PDBu).  Isometric tension was measured using a Grass FT03 force-
displacement transducer and a Grass model 7D polygraph.  Rings were removed from the 
bath at selected intervals of contraction and cut longitudinally, placed adventitia down on 
aluminum foil and snap frozen in liquid nitrogen.  Samples were maintained at -70°C 
until sectioned. 
 
Cell culture.  A7r5 smooth muscle cells derived from embryonic rat aorta and shown to 
maintain the ability to contract to phorbol esters (Fultz et al. 2000), were obtained from 
American Type Culture Collection (Manasass, VA).  Cells were plated on 75 cm2 flasks 
and grown to approximately 80% confluence at 37°C in a humidified atmosphere of 5% 
CO2 in air.  The cells were maintained in Dulbecco’s modified Eagles medium (DMEM) 
supplemented with 10% fetal calf serum, 100 units ml-1 penicillin G, and 100 µg ml-1 
streptomycin.  Media was changed every other day and cells were passaged at least once 
a week. 
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Confocal microscopy.  Cells were seeded onto glass coverslips, placed in 6 well culture 
plates and returned to the incubator to allow for attachment and spreading.  After 
treatment with PDBu (10-7 M) the cells were immediately fixed and permeabilized by 
addition of ice-cold acetone for 1.0 minute.  The cells were then washed several times 
with phosphate-buffered saline (PBS) containing 0.5% TWEEN-20 (PBS-T), pH 7.5, 
followed by a 60 minute incubation in blocking solution containing 5% nonfat dry milk 
in PBS.  Aortic rings from individual rats were selected for study at the onset of PDBu-
induced force development (0.3g tension), approximately midway through the 
contraction (2.5g tension), and 15 minutes after the plateau in tension.  Tissues were 
sectioned at 8 µm longitudinally on an IEC cryotome and placed on poly-L-lysine coated 
slides.  Sections were then fixed and permeablized by addition of ice-cold acetone for 1.0 
minute.  The slides were rinsed (3X) with PBS-T and preblocked with 5% nonfat dry 
milk in PBS.  Antibodies against SM1 and SM2 were obtained from Seikagaku America 
of the Associates of Cape Cod, Inc. (East Falmouth, MA).  Alexa-conjugated secondary 
antibodies were obtained from Molecular Probes, Inc. (Eugene, OR).  Samples were 
blocked with 5% non-fat milk in PBS.  Washings between steps were performed with 
0.5% Tween-20 in PBS.  Samples were incubated overnight in a solution of SM1 or SM2 
antibodies in PBS.  This was followed with incubation with secondary anti-mouse 
antibodies conjugated with Alexa-488.  α-Actin and β-actin were visualized using 
monoclonal anti-α-smooth muscle actin, clone 1A4 (IgG2a) and anti-β-actin, clone AC-
15 (IgG1) primary antibodies (Sigma, St. Louis, MO), respectively, followed by Alexa 
546 anti-IgG secondary antibody (Molecular Probes).  Cell and tissue samples were 
imaged with a Nikon Diaphot Microscope and confocal microscopy performed with a 
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BioRad Model 1024 scanning system with a krypton/argon laser.  Cells were viewed at 
600X magnification and tissue sections were viewed at 1000x.  The numerical aperture of 
the objective was 1.4.  The thickness of the section analyzed was 0.5 µm.  Controls to test 
for non-specific binding of primary antibodies and secondary antibodies were performed 
and no significant non-specific binding was visible. 
 
FRET analysis.  In the present study, we utilized the approach of measuring donor 
molecule quenching in the presence of acceptor fluorophore as an index of FRET 
(Kenworthy 2001).  This approach to FRET evaluation is amenable to immunostaining 
and confocal imaging of fixed biological samples (Dykes et al. 2003).  It must be noted, 
however, that the method as presently employed assumes that such factors as the 
absorption coefficient of the acceptor, the quantum yield of the donor, relative antibody 
binding affinity and the relative orientation of donor/acceptor antibody complexes, 
remain constant between treatment groups.  Within a FRET system two fluorophores 
with overlapping emission and excitation spectra are utilized.  Here myosin isoforms 
were labeled with Alexa 488 (excitation, 488 nm; emission, 520 nm) and served as the 
donor component of the system.  Actin isoforms were labeled with Alexa 546 (excitation, 
546 nm; emission, 580 nm) and served as the acceptor component.  The donor molecule 
(SM1 or SM2, Alexa 488) was directly excited and the resulting emission was obtained 
with a 522DF32 band pass filter.  However, a portion of the energy of emission was not 
released as light but was transferred to neighboring Alexa 546 fluorophore resulting in 
emission which was captured on a second channel with an HQ 598/40 band-pass filter.  
Subsequently, the image was excited at the 568 nm laser line at 100% power to 
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photobleach the acceptor molecule (actin) and a second image of the cell or tissue was 
acquired again at the 488 nm laser line excitation with the multichannel filter set to obtain 
myosin fluorescence (522DF32) and to verify the absence of actin label Alexa 546 
emission (HQ 598/40).  An intensity profile was generated for each sample (Image J 
Software, NIH) and the resulting plot was analyzed with Peakfit V4.11 software (SPSS 
Science, Richmond, CA) to obtain the area under the curve.  The values were then used 
to calculate the percent increase in fluorescence emission after photobleaching.   
Resonance energy transfer can only occur if the donor and acceptor molecules are close 
enough to each other for the transfer to occur efficiently.  Hence, the resulting values 
were analyzed in comparisons of control and PDBu-treated A7r5 cells and aortic tissue 
samples as an index of the association between actin and myosin during PDBu-induced 
contraction. 
 
Protein collection.  Aorta smooth muscle samples were pooled from each of the specific 
time points from specific days of collection.  Tissue samples were placed in lysis buffer 
(10mM MOPS, 1% NP-40, 5mM EDTA, 0.0mM EGTA, 1mM DTT, 50mM MgCl2, 
300mM NaCl, 1mM PMSF, 50µg/mL leupeptin, chymostatin, and pepstatin A) and 
ground using a glass-on-glass Con-Torque Power Unit motorized homogenizer 
(Eberbach, Corp., Ann Harbor, MI) and then sonicated for 3-4 times for 10 seconds each 
time with an ultrasonic homogenizer (Cole-Power Instrument Co., Chicago, IL).  Protein 
concentration was determined by bicinchoninic acid (BCA) protein assay (Pierce, 
Rockford, IL) or spectroscopically by measuring at the 280 nm wavelength.   
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Co-immunoprecipitation.  Equal amounts of protein from pooled samples of tissue 
lysate at each of the time points of contraction were incubated with either α-actin or β-
actin antibodies overnight.  The antibodies complexes were then cross-linked with 
Protein A/G beads (Pierce) for over two hours.  Samples were washed extensively (6X) 
in PBS and protein was removed from beads by adding SDS-PAGE sample buffer 
(125mM Tris-HCl, 4% SDS, 20% glycerol, 10% 2-mercaptoethanol, 0.004% 
bromophenol blue) and heating at 100°C for 10 minutes.  Samples were then stored at 
4°C. 
 
Gel electrophoresis and Western Blot analysis.  Equal volumes of samples from the 
co-immunoprecipitation experiment were boiled for five minutes and centrifuged for five 
minutes to bring the protein beads to the bottom of the tube.  Equal amounts of 
supernatant (20-50µL) were run on a 5% polyacrylamide gel for over 4 hours at 30 
mAmps in order to separate the myosin heavy chain isoforms.  Protein was then 
transferred to PVDF membrane (Amersham Pharmacia Biotech, Piscataway, NJ) for one 
hour with a Mini-Trans blot apparatus (BioRad, Hercules, CA).  Membranes were 
blocked in 5% non-fat powdered milk in PBS.  Membranes were incubated with an IgM 
anti-pan myosin antibody (Covance, Berkeley, CA).  After washing with 0.1% Tween-20 
in PBS (3X), membranes were incubated with an anti-IgM secondary antibody 
conjugated with horseradish peroxidase (Kirkegaard & Perry Laboratories, Gaithersburg, 
MD).  Bands were visualized with ECL or ECL Plus (Amersham).  Densitometry of 
bands was determined with ImageJ. 
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Statistics.  Differences in the index of actin/myosin association were analyzed by 
ANOVA followed by Student’s t-test (Sigma Stat 2.03, SPSS Science).  Differences were 
considered significant if P < 0.05 in all cases.  Data are presented as means ±  SEM 
throughout the text. 
 
Results 
 
A7r5 Smooth Muscle Cells.  Confocal images of A7r5 cells were examined to determine 
the association of α-actin with SM2 (Figure 1).  Similar to previous findings (Fultz and 
Wright 2003) actin stress fibers were visible in the control cell with which myosin has 
been shown to colocalize.  SM2 was highly visible in the vicinity of the nucleus in the 
control cell but generally absent from stress fibers.  PDBu (10-7M) treated cells showed 
fewer stress fibers with α-actin translocated to the brightly fluorescing podosomes.  There 
appeared to be little or no colocalization of SM2 with α-actin in the contracted cell.  It 
has been shown previously that β-actin remodels differently than α-actin (Fultz et al. 
2000; Brown et al. 2006), with β-actin remaining in stress fibers at physiological levels of 
contractile stimulation.  Similar to these previous findings, β-actin was observed in stress 
fibers of both control and PDBu-treated cells.  However, there was little or no evidence 
of significant SM2 colocalization with β-actin in either condition (Figure 2).  Consistent 
with colocalization results FRET analysis indicated little association between SM2 and 
either of the actin isoforms (Table 1).   
 
Control A7r5 cells that were dual stained for α-actin (Figure 3) or β-actin (Figure 4) and 
SM1 show little evidence of colocalization.  Contracted cells show the formation of 
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podosomes with obvious colocalization of α-actin and SM1 at these structures.  FRET 
analysis (Table 2) suggests a somewhat higher association of SM1 than SM2 with each 
actin isoform tested.  Despite the apparent colocalization of SM1 with α-actin in 
podosomes there was a tendency for a decrease in association in the contracted cell, 
although this decrease was not statistically significant.   
 
Aortic Vascular Smooth Muscle.  Rat aorta smooth muscle tissue was examined in 
order to determine the amount of association between α-actin and β-actin and the tail 
isoforms of smooth muscle myosin, SM1 and SM2.  Tissues dual stained for α-actin and 
SM2 (Figure 5) shows the confusion of structure typically seen in these studies.  
However, colocalization of α-actin and SM2 is visible in both control and contracted 
(Endpoint) tissue (Figure 5).  In comparison to cultured cells, SM2 is much more visible 
which would be consistent with earlier reports that SM2 becomes more highly expressed 
in differentiated adult tissue (Kuro-o et al. 1989).  Tissue dual stained for β-actin and 
SM2 (Figure 6) showed strong colocalization which appeared to be higher in control 
tissue than contracted tissue.  FRET analysis (Table 3) indicated relatively strong 
association in controls with a trend for disassociation of SM2 from each of the actin 
isoforms during the course of contraction, although decreasing significantly only in SM2-
β-actin interaction.   
 
Based on the review of ten or more sections per time point, the colocalization of SM1 
with α-actin (Figure 7) and β-actin (Figure 8) appeared to be stronger in control than in 
contracted tissue.  FRET analysis suggests that the association of SM1 with α-actin was 
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greater than for β-actin in controls.  However, similar to SM2, the SM1 association with 
actin isoforms showed decline during contraction (Table 4).  This was particularly 
dramatic in the SM1- β-actin interaction in which decreases of 88% to 95% were 
observed in the later phases of contraction.  Our results could reflect  cytoskeletal 
remodeling and rearrangement of the contractile apparatus as reported by others (Seow et 
al. 2000; Herrera et al. 2004; Herrera et al. 2005) but further suggest that active 
actin/myosin interaction declines as the contraction progresses. 
 
Co-immunoprecipitation experiments verified the results of FRET studies indicating a 
tendency for actin and myosin isoforms change association during contraction (Table 5, 
Figure 9).  Very similar to FRET results, co-immunoprecipitation indicated reductions in 
β-actin-myosin association to non-detectable levels during contraction (Figure 10). 
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Figures 
 
Figure 1.  Dual immunostaining of α-actin and SM2 in unstimulated (Control) and 
PDBu-activated A7r5 cells.  At 30 minutes after PDBu (10-7 M) addition, cells were fixed 
with acetone and prepared for confocal imaging.  α-Actin was visualized with a 
monoclonal anti-α-smooth muscle actin, clone 1A4 antibody.  SM2 was visualized with a 
monoclonal anti-SM2 antibody, clone 3F8.  Yellow color indicates colocalization of the 
two proteins.  Arrow is pointing out a patch of podosomes.  The white bar indicates 20 
µm. 
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Figure 2.  Dual immunostaining of β-actin and SM2 in unstimulated (Control) and 
PDBu-activated A7r5 cells.  At 30 minutes after PDBu (10-7 M) addition, cells were fixed 
with acetone and prepared for confocal imaging.  β-Actin was visualized with a 
monoclonal anti-β-smooth muscle actin, clone AC-15 antibody.  SM2 was visualized 
with a monoclonal anti-SM2 antibody, clone 3F8.  Yellow color indicates colocalization 
of the two proteins.  The white bar indicates 20 µm. 
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Figure 3.  Dual immunostaining of α-actin and SM1 in unstimulated (Control) and 
PDBu-activated A7r5 cells.  At 30 minutes after PDBu (10-7 M) addition, cells were fixed 
with acetone and prepared for confocal imaging.  α-Actin was visualized with a 
monoclonal anti-α-smooth muscle actin, clone 1A4 antibody.  SM1 was visualized with a 
monoclonal anti-SM1 antibody, clone 1G12.  Yellow color indicates colocalization of the 
two proteins.  The white bar indicates 20 µm. 
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Figure 4.  Dual immunostaining of β-actin and SM1 in unstimulated (Control) and 
PDBu-activated A7r5 cells.  At 30 minutes after PDBu (10-7 M) addition, cells were fixed 
with acetone and prepared for confocal imaging. β-Actin was visualized with a 
monoclonal anti-β-smooth muscle actin, clone AC-15 antibody.  SM1 was visualized 
with a monoclonal anti-SM1 antibody, clone 1G12.  Yellow color indicates 
colocalization of the two proteins.  The white bar indicates 20 µm. 
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Figure 5.  Dual immunostaining of α-actin and SM2 in unstimulated (Control) and 
PDBu-activated aorta tissue.  Sections were fixed with ice cold acetone.  α-Actin was 
visualized with a monoclonal anti-α-smooth muscle actin, clone 1A4 antibody.  SM2 was 
visualized with a monoclonal anti-SM2 antibody, clone 3F8.  Yellow color indicates 
colocalization of the two proteins.  The white bar indicates 10 µm. 
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Figure 6.  Dual immunostaining of β-actin and SM2 in unstimulated (Control) and 
PDBu-activated aorta tissue.  Sections were fixed with ice cold acetone.  β-Actin was 
visualized with a monoclonal anti-β-smooth muscle actin, clone AC-15 antibody.  SM2 
was visualized with a monoclonal anti-SM2 antibody, clone 3F8.  Yellow color indicates 
colocalization of the two proteins.  The white bar indicates 10 µm. 
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Figure 7.  Dual immunostaining of α-actin and SM1 in unstimulated (Control) and 
PDBu-activated aorta tissue.  Sections were fixed with ice cold acetone.  α-Actin was 
visualized with a monoclonal anti-α-smooth muscle actin, clone 1A4 antibody.  SM1 was 
visualized with a monoclonal anti-SM1 antibody clone 1G12.  Yellow color indicates 
colocalization of the two proteins.  The white bar indicates 10 µm. 
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Figure 8.  Dual immunostaining of β-actin and SM1 in unstimulated (Control) and 
PDBu-activated aorta tissue.  Sections were fixed with ice cold acetone.  β-Actin was 
visualized with a monoclonal anti-β-smooth muscle actin, clone AC-15 antibody.  SM1 
was visualized with a monoclonal anti-SM1 antibody clone 1G12.  Yellow color 
indicates colocalization of the two proteins.  The white bar indicates 10 µm. 
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Figure 9.  Representative gel image of Western blot analysis of samples co-
immunoprecipitated with anti-α-smooth muscle actin, clone 1A4 antibody.  Myosin 
bands were visualized with an IgM-pan-myosin antibody and an anti-IgM secondary 
antibody conjugated with horseradish peroxidase.  Upper band is the 204kDa SM1 and 
the lower is 200kDa SM2.  L: Kaleidoscope ladder (Bio-Rad) (Myosin band is visible); 
C: Control; B: Beginning of contraction; M: Midpoint of contraction; E: Endpoint of 
contraction. 
 
 
 
SM1 
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Figure 10.  Western blot analysis of samples co-immunoprecipitated with anti-β-smooth 
muscle actin, clone AC-15 antibody.  Myosin bands were visualized with an IgM-pan-
myosin antibody and an anti-IgM secondary antibody conjugated with horseradish 
peroxidase.  Upper band is the 204kDa SM1 and the lower is 200kDa SM2.   L: 
Kaleidoscope ladder (Bio-Rad) (Myosin band is visible); C: Control; B: Beginning of 
contraction; M: Midpoint of contraction; E: Endpoint of contraction. 
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Tables 
 
Table 1. Fluorescence resonance energy transfer (FRET) analysis of the association of 
SM2 myosin with α- and β-actin in Control and PDBu-stimulated A7r5 cells.  The SM2 
myosin isoform was visualized using monoclonal anti-SM2 antibodies.  α-Actin and β-
actin were visualized with monoclonal anti-α smooth muscle actin clone 1A4 and anti-β-
actin clone AC-15 antibodies, respectively.  Values represent the average of a minimum 
of 20 cells and reflect the percent increase in the fluorescence of the donor fluorophore 
(SM2) after photobleaching the acceptor fluorophore actin. 
                             
Actin Isoform Control Contracted 
α-Actin 5.8 ± 1.8 % 8.8 ± 1.2 % 
β-Actin 9.6 ± 1.2 % 7.5 ± 1.3 % 
  
 
 
Table 2. Fluorescence resonance energy transfer (FRET) analysis of the association of 
SM1 myosin with α- and β-actin in Control and PDBu-stimulated A7r5 cells.  The SM1 
myosin isoform was visualized using monoclonal anti-SM1 antibodies.  α-Actin and β-
actin were visualized with monoclonal anti-α smooth muscle actin clone 1A4 and anti-β-
actin clone AC-15 antibodies, respectively.  Values represent the average of a minimum 
of 20 cells and reflect the percent increase in the fluorescence of the donor fluorophore 
(SM1) after photobleaching the acceptor fluorophore actin. 
Actin Isoform Control Contracted 
α-Actin 13.9 ± 1.9 % 9.6 ± 1.4 % 
β-Actin 17.7 ± 2.0 % 11.6 ± 2.1 % 
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Table 3. Fluorescence resonance energy transfer (FRET) analysis of the association of 
SM2 with α- and β-actin in Control, Beginning, Midpoint, and Endpoint time points of 
PDBu-stimulated rat aorta smooth muscle tissue.  SM2 was visualized using monoclonal 
anti-SM2 antibodies.  α-Actin and β-actin were visualized with monoclonal anti-α 
smooth muscle actin clone 1A4 and anti-β-actin clone AC-15 antibodies, respectively.  
Values represent the average of a minimum of 10 sections and reflect the percent increase 
in fluorescence of the donor fluorophore (SM2) after photobleaching the acceptor 
fluorophore actin.   * Denotes p< 0.05 when compared to control. 
Actin Isoform Control Beginning Midpoint Endpoint 
α-Actin 20.7 ± 2.1 % 15.0 ± 3.1 % 14.0 ± 4.5 % 11.0 ± 4.8 % 
β-Actin 21.1 ± 4.6 % 2.6 ± 3.3 %* 15.6 ± 3.0 % 7.9 ± 3.4 %* 
 
 
Table 4. Fluorescence resonance energy transfer (FRET) analysis of the association of 
SM1 with α- and β-actin in Control, Beginning, Midpoint, and Endpoint time points of 
PDBu-stimulated rat aorta smooth muscle tissue.  SM1 was visualized using monoclonal 
anti-SM1 antibodies.  α-Actin and β-actin were visualized with monoclonal anti-α 
smooth muscle actin clone 1A4 and anti-β-actin clone AC-15 antibodies, respectively.  
Values represent the average of a minimum of 10 sections and reflect the percent increase 
in fluorescence of the donor fluorophore (SM1) after photobleaching the acceptor 
fluorophore actin.  * Denotes p<0.05 when compared to control. 
Actin Isoform Control Beginning Midpoint Endpoint 
α-Actin 34.3 ± 5.4 % 28.7 ± 3.2 % 21.8 ± 2.6 %* 23.9 ± 3.7 % 
β-Actin 15.0 ± 2.8 % 5.8 ± 3.7 % 0.08 ± 3.3 %* 1.9 ± 2.2 %* 
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Table 5.  Co-immunoprecipitation experiment results.  Equal protein concentrations from 
aorta tissue lysate were treated with monoclonal anti-α smooth muscle actin clone 1A4.  
SDS-PAGE was performed on each sample and Western blots were performed using 
clone C5C.52 pan-anti-myosin antibody.  Densitometry was performed on visualized 
bands and results were normalized to control levels.   
Myosin 
Isoform 
Control Beginning Midpoint Endpoint 
SM1 100 % 72 ± 27 % 29 ± 16 % 46 ± 39 % 
SM2 100 % 81 ± 28 % 56 ± 54 % 100 ± 18 % 
 
 
 
Discussion 
 
Our laboratory has reported that actin remodeling is an important element of contraction 
of aorta smooth muscle (Wright and Hurn 1994) and A7r5 embryonic rat aortic cells 
(Fultz et al. 2000).  We have also shown that myosin remodels in the A7r5 cells during 
phorbol stimulated contraction (Fultz and Wright 2003).  Such remodeling has also been 
verified by others (Mehta and Gunst 1999; Seow et al. 2000; Herrera et al. 2002; 
Burgstaller and Gimona 2004; Herrera et al. 2005).  However, the exact nature of this 
remodeling, the mechanisms regulating it, and the means by which it conveys contractile 
properties to smooth muscle is still unknown.  One centrally important question is how 
the different actin and myosin isoforms interact during remodeling.  Our laboratory has 
shown that α-actin and β-actin remodel differently in the A7r5 cell model when the cells 
are contracted with phorbol (Fultz et al. 2000; Brown et al. 2006).  It is not certain to 
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what extent that actin and myosin remain associated during the dramatic reorganization 
of cytoskeletal actin (Fultz and Wright 2003).   
 
There has been debate surrounding the different roles of the myosin tail isoforms, SM1 
and SM2, in smooth muscle.  Enzymatic activity differences in the myosin isoform have 
been attributed to the head isoforms (Rovner et al. 1997); whereas, it is thought that the 
tail isoforms are linked to structural differences in filaments and cell length (Meer and 
Eddinger 1997; Rovner et al. 2002) as well as to enzymatic activity (Martin et al. 1997).  
The present study focused on the tail isoforms and their associations with actin isoforms 
in the remodeling of the contractile apparatus in aorta smooth muscle.  As a part of this 
investigation we utilized FRET analysis of protein-protein interaction.  FRET is only 
effective when the fluorescent molecules are within 10nm of one another (Selvin 2000; 
Kenworthy 2001; Jares-Erijman and Jovin 2003).  Because the SM1 and SM2 antibodies 
we used are specific for the different tail regions of myosin, the measurements we report 
are indicative of the association of myosin filaments containing these isoforms with thin 
filaments of α-actin or β-actin which have been shown in the side-by-side arrangements 
in smooth muscle (Herrera et al. 2004; Herrera et al. 2005).   
 
Selvin (2000) has suggested that FRET is better suited to the determination of changes in 
distance rather than absolute distances.  For this reason, in our studies we have compared 
the differences (decreases/increases) of FRET values between samples at control and 
different time points in the contraction as an indicator of changes in actin-myosin 
association. 
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Studies with A7r5 smooth muscle cells verified previous findings (Fultz et al. 2000; Fultz 
and Wright 2003) regarding the extensive remodeling of the actin-myosin cytoskeletal 
system.  FRET analysis suggested only minor levels of actin-myosin isoform association.  
There were no significant changes in FRET indices of association between control and 
PDBu-contracted cells although a trend for decreased interaction was noted for SM1 and 
actin isoforms of contracted cells (Table 1, 2). 
 
By comparison, tissues showed evidence of highly significant levels of actin-myosin 
association (Tables 3, 4).  Moreover, both SM2 and SM1 showed a strong tendency for 
decreased association with α-actin and highly significant reductions in the association of 
these isoforms with β-actin during the course of the PDBu-induced contraction.  
Differences between cells in culture and freshly isolated tissue could be due to 
differences in isoform expression, the fact that tissue cells are embedded in a matrix and 
are subject to cell-cell interaction, the loading (stretch) of tissues prior to contraction, or 
other differences between the two models.  Although the apparent disassociation of actin 
and myosin during intervals of peak force development was unexpected these results 
were verified by co-immunoprecipitation experiments and are consistent with earlier 
confocal studies of actin-myosin colocalization in cells (Fultz and Wright 2003).  
Importantly, these results are in direct opposition to the “latch” mechanism proposed by 
Hai and Murphy (1992) to explain the low energy cost of tension maintenance in smooth 
muscle.  An alternate explanation is that during contractile remodeling cross-linking of 
actin filaments could hold the cell in the contracted configuration at low energy cost 
(Battistella-Patterson et al. 1997).          
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Chapter IV 
Summary and Conclusion 
General Discussion.  Smooth muscle contraction has been a topic of investigation in our laboratory 
for well over a decade.  Much work has focused on actin isoforms and the remodeling of actin and 
myosin during contraction.  However, a major gap in the knowledge developed by our laboratory and 
others is in the relationship of actin and myosin during contraction in which both filament types are 
seen to undergo substantial reorganization.  Secondly, it would be important to establish if cytoskeletal 
remodeling seen in isolated cells is comparable to that occurring in differentiated cells in tissue.  In the 
studies presented in this dissertation, we have used both the A7r5 cell model and rat aorta rings to 
examine smooth muscle contraction in cells and tissue contracted with phorbol-12, 13-dibutyrate 
(PDBu).  Confocal microscopy has been our primary method of observing the activity of cytoskeletal 
remodeling and contractile apparatus rearrangement at the cellular level.  In addition, we have used a 
well-established technique, fluorescent resonance energy transfer (FRET) in a novel way to examine 
the myosin-actin protein interaction during contraction.  Finally, we used another well-established 
technique, co-immunoprecipitation, to confirm the results of our FRET analysis. 
 
We first examined the association of smooth muscle myosin with α-actin and β-actin isoforms in A7r5 
cells.  Our results show that these associations are not static, but change throughout contraction.  
Comparison of endpoint to control showed a large decrease of myosin association with α-actin, but 
association with β-actin remained unchanged.  Time course studies showed that the association of 
myosin with α-actin increased at the initiation of contraction but decreased as the contraction 
continued.  Our studies in tissue showed similar results; however, the association of myosin with α-
actin increased at the endpoint of contraction.  This difference between cells and tissue is an important 
  118
observation and can be attributed to the difference in the models.  Isolated cells are not under constant 
tension, but are “unloaded”, whereas the aorta rings were maintained under constant tension.  Perhaps 
more importantly, cells in tissue are embedded in a matrix and are subject to extensive cell-cell 
interaction.  In tissue, myosin association with β-actin remained unchanged except for a significant 
decrease during the midpoint of contraction.  By comparison association with α-actin increased at the 
start and end but, similar to β-actin, decreased at the midpoint of contraction.  Based on these data, we 
suggest that the midpoint of contraction is a significant time of remodeling of the contractile apparatus 
in which the association of myosin with each isoform of actin is decreased.  Studies using phalloidin 
staining support this contention indicating that at the midpoint tissues had less F-actin content than 
seen in the beginning and end of contraction.  We also report the occurrence of large actin fibers and 
patches throughout contraction of tissue.  We concluded that these results suggest heterogeneous 
remodeling of the cytoskeleton and rearrangement of the contractile apparatus takes place during 
contraction of rat aorta smooth muscle, likely in response to heterogeneous strain resulting from 
internal force development.  This reorganization and focus of contractile machinery at specific points 
of strain could explain how smooth muscle develops strong contractile force with relatively low levels 
of myosin. 
 
Our next study examined the changes in interaction of the different myosin carboxyl isoforms, SM1 
and SM2, with α-actin and β-actin.  Studies in A7r5 cells showed that the interaction of SM1 with each 
actin isoform tended to be decreased during contraction compared to control; whereas SM2 interaction 
with each actin isoform was unchanged, again indicating isoform specific remodeling.  In tissue, the 
interaction of SM1 and SM2 with α-actin was similar and tended to decrease with contraction.  The 
interaction with β-actin was also similar with both myosin isoforms showing a dramatic decrease in 
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association once contraction began.  Co-immunoprecipitation experiments showed similar trends as 
seen with FRET analysis.  β-Actin association with each myosin isoform was shown to be undetectable 
at all time points of contraction, while the interaction with α-actin was only slightly changed.  These 
results confirm that significant remodeling of the contractile apparatus occurs with the actin isoforms 
interacting differently with myosin isoforms.  In addition, these findings further suggest that the full 
complement of the actin-myosin complex is not utilized at peak points of force development.  
 
These studies provide evidence against the suggestion that smooth muscle maintains tension with low 
energy output with slow cycling myosin-actin crossbridges, the “latch” hypothesis.  What we see is not 
increased actin-myosin association at the endpoint of contraction, but the opposite.  Myosin appears to 
disassociate from actin, yet tension is maintained.  The hypothesis proposed by our laboratory has been 
that tension is maintained via cross-linking of the actin cytoskeleton.  The actin fibers remodel and 
reorganize throughout smooth muscle contraction.  These fibers are then cross-linked, possibly by 
myosin, and the apparatus is in essence “locked-up” at its contracted length.  This enables the cell to 
remain contracted with very low energy expenditure.  These studies provide evidence that supports this 
hypothesis. 
 
 Future work.  Ideally, FRET should be performed with fluorescent molecules directly attached to the 
molecules under examination.  Doing this with myosin and actin would be an important step in 
confirming these results.  In such experiments one could examine both filament association as well as 
the interaction of the myosin head with actin.  Another aspect that could be examined is the importance 
of the myosin head isoforms in this remodeling of the contractile apparatus.  It has been reported that 
these isoforms affect the enzymatic activity of myosin, but they could also contribute to a structural 
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role.    Finally, using a modified cell model with aorta cells cultured in a collagen matrix could allow a 
more detailed view of the influence of the matrix and cell-cell interaction on results.  Of great interest 
is the finding that actin-myosin association declines during contraction.  This observation provides 
direct evidence against the “latch” hypothesis of tension maintenance and supports our early 
contention that the low energy cost of this activity could be due to locking of the cytoskeleton in the 
contracted configuration by cross-linking of filaments.  Future studies of cross-linking activity during 
contraction would, therefore be interesting in testing this hypothesis. 
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